Publications 2024

Carlsen MH, Totland TH, Kumar R, Lensnes TM, Sharma A, Suntharalingam AA, Tran AT, Birkeland KI, Sommer C (2024)
Evaluation of a digital FFQ using 24 h recalls as reference method, for assessment of habitual diet in women with South Asian origin in Norway
Public Health Nutr, 27 (1), e55
DOI 10.1017/S1368980024000302, PubMed 38316533

Linares-Pineda TM, Fragoso-Bargas N, Picón MJ, Molina-Vega M, Jenum AK, Sletner L, Lee-Ødegård S, Opsahl JO, Moen GH, Qvigstad E, Prasad RB, Birkeland KI, Morcillo S, Sommer C (2024)
DNA methylation risk score for type 2 diabetes is associated with gestational diabetes
Cardiovasc Diabetol, 23 (1), 68
DOI 10.1186/s12933-024-02151-z, PubMed 38350951

Opsahl JO, Fragoso-Bargas N, Lee Y, Carlsen EØ, Lekanova N, Qvigstad E, Sletner L, Jenum AK, Lee-Ødegård S, Prasad RB, Birkeland KI, Moen GH, Sommer C (2024)
Epigenome-wide association study of DNA methylation in maternal blood leukocytes with BMI in pregnancy and gestational weight gain
Int J Obes (Lond), 48 (4), 584-593
DOI 10.1038/s41366-024-01458-x, PubMed 38219005

Sletner L, Yajnik CS, Turowski G, Michelsen TM, Sommer C, Birkeland KI, Roald B, Jenum AK (2024)
Placental weight, surface area, shape and thickness - Relations with maternal ethnicity and cardio-metabolic factors during pregnancy
Placenta, 148, 69-76
DOI 10.1016/j.placenta.2024.02.002, PubMed 38417304

Publications 2023

Birkeland KI, Meling S, Alsnes IV, Svensson E, Gullestad L, Jenssen TG (2023)
New international recommendations for type 2 diabetes - consequences for treatment practice in Norway?
Tidsskr Nor Laegeforen, 143 (3)
DOI 10.4045/tidsskr.22.0672, PubMed 36811420

Fragoso-Bargas N, Elliott HR, Lee-Ødegård S, Opsahl JO, Sletner L, Jenum AK, Drevon CA, Qvigstad E, Moen GH, Birkeland KI, Prasad RB, Sommer C (2023)
Cross-Ancestry DNA Methylation Marks of Insulin Resistance in Pregnancy: An Integrative Epigenome-Wide Association Study
Diabetes, 72 (3), 415-426
DOI 10.2337/db22-0504, PubMed 36534481

Fragoso-Bargas N, Page CM, Joubert BR, London SJ, Lee-Ødegård S, Opsahl JO, Sletner L, Jenum AK, Qvigstad E, Prasad RB, Moen GH, Birkeland KI, Sommer C (2023)
Epigenome-wide association study of serum folate in maternal peripheral blood leukocytes
Epigenomics, 15 (1), 39-52
DOI 10.2217/epi-2022-0427, PubMed 36974632

Goh SY, Kosiborod MN, Lam CSP, Cavender MA, Kohsaka S, Norhammar A, Birkeland KI, Holl RW, Mauricio D, Tangri N, Shaw JE, Thuresson M, Fenici P, Kim DJ, CVD-REAL Investigators and Study Group (2023)
Lower risk of cardiovascular events and death associated with initiation of sodium-glucose cotransporter-2 inhibitors versus sulphonylureas: Analysis from the CVD-REAL 2 study
Diabetes Obes Metab, 25 (8), 2402-2409
DOI 10.1111/dom.15092, PubMed 37055714

Graue M, Igland J, Haugstvedt A, Hernar I, Birkeland KI, Zoffmann V, Richards DA, Kolltveit BH (2023)
Evaluation of an interprofessional follow-up intervention among people with type 2 diabetes in primary care-A randomized controlled trial with embedded qualitative interviews
PLoS One, 18 (11), e0291255
DOI 10.1371/journal.pone.0291255, PubMed 37967084

Jersin RÅ, Sri Priyanka Tallapragada D, Skartveit L, Bjune MS, Muniandy M, Lee-Ødegård S, Heinonen S, Alvarez M, Birkeland KI, André Drevon C, Pajukanta P, McCann A, Pietiläinen KH, Claussnitzer M, Mellgren G, Dankel SN (2023)
Impaired Adipocyte SLC7A10 Promotes Lipid Storage in Association With Insulin Resistance and Altered BCAA Metabolism
J Clin Endocrinol Metab, 108 (9), 2217-2229
DOI 10.1210/clinem/dgad148, PubMed 36916878

Lee S, Norheim F, Langleite TM, Gulseth HL, Birkeland KI, Drevon CA (2023)
Correction to: Effects of long-term exercise on plasma adipokine levels and inflammation-related gene expression in subcutaneous adipose tissue in sedentary dysglycaemic, overweight men and sedentary normoglycaemic men of healthy weight
Diabetologia, 66 (2), 410
DOI 10.1007/s00125-022-05841-z, PubMed 36445395

Moore TM, Lee S, Olsen T, Morselli M, Strumwasser AR, Lin AJ, Zhou Z, Abrishami A, Garcia SM, Bribiesca J, Cory K, Whitney K, Ho T, Ho T, Lee JL, Rucker DH, Nguyen CQA, Anand ATS, Yackly A, Mendoza LQ, Leyva BK, Aliman C, Artiga DJ, Meng Y, Charugundla S et al. (2023)
Conserved multi-tissue transcriptomic adaptations to exercise training in humans and mice
Cell Rep, 42 (5), 112499
DOI 10.1016/j.celrep.2023.112499, PubMed 37178122

Riise HKR, Graue M, Igland J, Birkeland KI, Kolltveit BH (2023)
Prevalence of increased risk of type 2 diabetes in general practice: a cross-sectional study in Norway
BMC Prim Care, 24 (1), 151
DOI 10.1186/s12875-023-02100-x, PubMed 37468831

Sommer C, Vangberg KG, Moen GH, Evans DM, Lee-Ødegård S, Blom-Høgestøl IK, Sletner L, Jenum AK, Drevon CA, Gulseth HL, Birkeland KI (2023)
Insulin and Body Mass Index Decrease Serum Soluble Leptin Receptor Levels in Humans
J Clin Endocrinol Metab, 108 (5), 1110-1119
DOI 10.1210/clinem/dgac699, PubMed 36459457

Waage CW, Toftemo I, Brænd AM, Sletner L, Sommer C, Birkeland KI, Richardsen KR, Shakeel N, Vøllestad NK, Jenum AK (2023)
Cohort profile update: the Norwegian STORK Groruddalen (STORK G) pregnancy and birth cohort-the role of ethnicity and causal pathways for obesity, type 2 diabetes, cardiovascular disease and other health issues
BMJ Open, 13 (10), e076251
DOI 10.1136/bmjopen-2023-076251, PubMed 37899145

Publications 2022

Bjarkø VV, Haug EB, Sørgjerd EP, Stene LC, Ruiz PL, Birkeland KI, Berg TJ, Gulseth HL, Iversen MM, Langhammer A, Åsvold BO (2022)
Undiagnosed diabetes: Prevalence and cardiovascular risk profile in a population-based study of 52,856 individuals. The HUNT Study, Norway
Diabet Med, 39 (6), e14829
DOI 10.1111/dme.14829, PubMed 35288977

Fatima F, Hjelmesæth J, Birkeland KI, Gulseth HL, Hertel JK, Svanevik M, Sandbu R, Småstuen MC, Hartmann B, Holst JJ, Hofsø D (2022)
Gastrointestinal Hormones and β-Cell Function After Gastric Bypass and Sleeve Gastrectomy: A Randomized Controlled Trial (Oseberg)
J Clin Endocrinol Metab, 107 (2), e756-e766
DOI 10.1210/clinem/dgab643, PubMed 34463768

Haugen AJ, Hallan S, Langberg NE, Dahle DO, Pihlstrøm H, Birkeland KI, Reisæter AV, Midtvedt K, Hartmann A, Holdaas H, Mjøen G (2022)
Increased risk of ischaemic heart disease after kidney donation
Nephrol Dial Transplant, 37 (5), 928-936
DOI 10.1093/ndt/gfab054, PubMed 33624826

Lee-Ødegård S, Olsen T, Norheim F, Drevon CA, Birkeland KI (2022)
Potential Mechanisms for How Long-Term Physical Activity May Reduce Insulin Resistance
Metabolites, 12 (3)
DOI 10.3390/metabo12030208, PubMed 35323652

Lee-Ødegård S, Ueland T, Thorsby PM, Aukrust P, Michelsen AE, Halvorsen B, Drevon CA, Birkeland KI (2022)
Fetuin-A mediates the difference in adipose tissue insulin resistance between young adult pakistani and norwegian patients with type 2 diabetes
BMC Endocr Disord, 22 (1), 208
DOI 10.1186/s12902-022-01127-y, PubMed 35978354

Norhammar A, Bodegard J, Eriksson JW, Haller H, Linssen GCM, Banerjee A, Karasik A, Mamouris P, Tangri N, Taveira-Gomes T, Maggioni AP, Botana M, Thuresson M, Okami S, Yajima T, Kadowaki T, Birkeland KI, CaReMe Cardiorenal Investigators (2022)
Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: A multinational, observational study across 12 countries
Diabetes Obes Metab, 24 (7), 1277-1287
DOI 10.1111/dom.14698, PubMed 35322567

Pervjakova N, Moen GH, Borges MC, Ferreira T, Cook JP, Allard C, Beaumont RN, Canouil M, Hatem G, Heiskala A, Joensuu A, Karhunen V, Kwak SH, Lin FTJ, Liu J, Rifas-Shiman S, Tam CH, Tam WH, Thorleifsson G, Andrew T, Auvinen J, Bhowmik B, Bonnefond A, Delahaye F, Demirkan A et al. (2022)
Multi-ancestry genome-wide association study of gestational diabetes mellitus highlights genetic links with type 2 diabetes
Hum Mol Genet, 31 (19), 3377-3391
DOI 10.1093/hmg/ddac050, PubMed 35220425

Sharma A, Lee-Ødegård S, Qvigstad E, Sommer C, Sattar N, Gill JMR, Gulseth HL, Sollid ST, Nermoen I, Birkeland KI (2022)
β-Cell Function, Hepatic Insulin Clearance, and Insulin Sensitivity in South Asian and Nordic Women After Gestational Diabetes Mellitus
Diabetes, 71 (12), 2530-2538
DOI 10.2337/db22-0622, PubMed 36112815

Sharma A, Nermoen I, Qvigstad E, Tran AT, Sommer C, Sattar N, Gill JMR, Gulseth HL, Sollid ST, Birkeland KI (2022)
High prevalence and significant ethnic differences in actionable HbA_1C after gestational diabetes mellitus in women living in Norway
BMC Med, 20 (1), 318
DOI 10.1186/s12916-022-02515-w, PubMed 36138475

Simeone P, Tripaldi R, Michelsen A, Ueland T, Liani R, Ciotti S, Birkeland KI, Gulseth HL, Di Castelnuovo A, Cipollone F, Aukrust P, Consoli A, Halvorsen B, Santilli F (2022)
Effects of liraglutide vs. lifestyle changes on soluble suppression of tumorigenesis-2 (sST2) and galectin-3 in obese subjects with prediabetes or type 2 diabetes after comparable weight loss
Cardiovasc Diabetol, 21 (1), 36
DOI 10.1186/s12933-022-01469-w, PubMed 35277168

Sundström J, Bodegard J, Bollmann A, Vervloet MG, Mark PB, Karasik A, Taveira-Gomes T, Botana M, Birkeland KI, Thuresson M, Jäger L, Sood MM, VanPottelbergh G, Tangri N, CaReMe CKD Investigators (2022)
Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: The CaReMe CKD study
Lancet Reg Health Eur, 20, 100438
DOI 10.1016/j.lanepe.2022.100438, PubMed 36090671

Teigland T, Igland J, Tell GS, Haltbakk J, Graue M, Fismen AS, Birkeland KI, Østbye T, Peyrot M, Iversen MM (2022)
The prevalence and incidence of pharmacologically treated diabetes among older people receiving home care services in Norway 2009-2014: a nationwide longitudinal study
BMC Endocr Disord, 22 (1), 159
DOI 10.1186/s12902-022-01068-6, PubMed 35701772

Teigland T, Igland J, Tell GS, Haltbakk J, Graue M, Fismen AS, Birkeland KI, Østbye T, Peyrot M, Iversen MM (2022)
Correction: The prevalence and incidence of pharmacologically treated diabetes among older people receiving home care services in Norway 2009-2014: a nationwide longitudinal study
BMC Endocr Disord, 22 (1), 176
DOI 10.1186/s12902-022-01091-7, PubMed 35836206

Waage CW, Mdala I, Stigum H, Jenum AK, Birkeland KI, Shakeel N, Michelsen TM, Richardsen KR, Sletner L (2022)
Lipid and lipoprotein concentrations during pregnancy and associations with ethnicity
BMC Pregnancy Childbirth, 22 (1), 246
DOI 10.1186/s12884-022-04524-2, PubMed 35331154

Publications 2021

Birkeland E, Gharagozlian S, Birkeland KI, Holm OKS, Thorsby PM, Aas AM (2021)
Effect of inulin-type fructans on appetite in patients with type 2 diabetes: a randomised controlled crossover trial
J Nutr Sci, 10, e72
DOI 10.1017/jns.2021.70, PubMed 34589204

Birkeland E, Gharagozlian S, Gulseth HL, Birkeland KI, Hartmann B, Holst JJ, Holst R, Aas AM (2021)
Effects of prebiotics on postprandial GLP-1, GLP-2 and glucose regulation in patients with type 2 diabetes: A randomised, double-blind, placebo-controlled crossover trial
Diabet Med, 38 (10), e14657
DOI 10.1111/dme.14657, PubMed 34297363

Bleskestad KB, Nordheim E, Lindahl JP, Midtvedt K, Pihlstrøm HK, Horneland R, Lee S, Åsberg A, Jenssen TG, Birkeland KI (2021)
Insulin secretion and action after pancreas transplantation. A retrospective single-center study
Scand J Clin Lab Invest, 81 (5), 365-370
DOI 10.1080/00365513.2021.1926535, PubMed 34075856

Fismen AS, Igland J, Teigland T, Tell GS, Ostbye T, Haltbakk J, Graue M, Birkeland KI, Peyrot M, Iversen MM (2021)
Pharmacologically treated diabetes and hospitalization among older Norwegians receiving homecare services from 2009 to 2014: a nationwide register study
BMJ Open Diabetes Res Care, 9 (1)
DOI 10.1136/bmjdrc-2020-002000, PubMed 33771766

Fragoso-Bargas N, Opsahl JO, Kiryushchenko N, Böttcher Y, Lee-Ødegård S, Qvigstad E, Richardsen KR, Waage CW, Sletner L, Jenum AK, Prasad RB, Groop LC, Moen GH, Birkeland KI, Sommer C (2021)
Cohort profile: Epigenetics in Pregnancy (EPIPREG) - population-based sample of European and South Asian pregnant women with epigenome-wide DNA methylation (850k) in peripheral blood leukocytes
PLoS One, 16 (8), e0256158
DOI 10.1371/journal.pone.0256158, PubMed 34388220

Kristófi R, Bodegard J, Norhammar A, Thuresson M, Nathanson D, Nyström T, Birkeland KI, Eriksson JW (2021)
Cardiovascular and Renal Disease Burden in Type 1 Compared With Type 2 Diabetes: A Two-Country Nationwide Observational Study
Diabetes Care, 44 (5), 1211-1218
DOI 10.2337/dc20-2839, PubMed 33653822

Langberg NE, Jenssen TG, Haugen AJ, Mjøen G, Birkeland KI, Åsberg A, Hartmann A, Dahle DO (2021)
Endothelial Dysfunction and 6-Year Risk of Mortality in Kidney Transplant Recipients
Transplant Direct, 8 (1), e1262
DOI 10.1097/TXD.0000000000001262, PubMed 34912949

Nordheim E, Lindahl JP, Carlsen RK, Åsberg A, Birkeland KI, Horneland R, Boye B, Scholz H, Jenssen TG (2021)
Patient selection for islet or solid organ pancreas transplantation: experiences from a multidisciplinary outpatient-clinic approach
Endocr Connect, 10 (2), 230-239
DOI 10.1530/EC-20-0519, PubMed 33544090

Sharma A, Birkeland KI, Nermoen I, Qvigstad E, Tran AT, Gulseth HL, Sollid ST, Wium C, Varsi C (2021)
Understanding mechanisms behind unwanted health behaviours in Nordic and South Asian women and how they affect their gestational diabetes follow-ups: A qualitative study
Diabet Med, 38 (10), e14651
DOI 10.1111/dme.14651, PubMed 34268812

Sletner L, Moen AEF, Yajnik CS, Lekanova N, Sommer C, Birkeland KI, Jenum AK, Böttcher Y (2021)
Maternal Glucose and LDL-Cholesterol Levels Are Related to Placental Leptin Gene Methylation, and, Together With Nutritional Factors, Largely Explain a Higher Methylation Level Among Ethnic South Asians
Front Endocrinol (Lausanne), 12, 809916
DOI 10.3389/fendo.2021.809916, PubMed 35002980

Stene LC, Ruiz PL, Åsvold BO, Bjarkø VV, Sørgjerd EP, Njølstad I, Hopstock LA, Birkeland KI, Gulseth HL (2021)
[L.C. Stene and colleagues respond]
Tidsskr Nor Laegeforen, 141 (1)
DOI 10.4045/tidsskr.20.1028, PubMed 33433091

Stene LC, Ruiz PLD, Asvold BO, Bjarko VV, Sorgjerd EP, Njolstad I, Hopstock LA, Birkeland KI, Gulseth HL (2021)
Diabetes in Norway - different methods give different prevalence estimates REPLY
Tidsskr. Nor. Laegeforen., 141 (1), 12

Øyen J, Brantsæter AL, Nøstbakken OJ, Birkeland KI, Haugen M, Madsen L, Egeland GM (2021)
Intakes of Fish and Long-chain n-3 Polyunsaturated Fatty Acid Supplements During Pregnancy and Subsequent Risk of Type 2 Diabetes in a Large Prospective Cohort Study of Norwegian Women
Diabetes Care, 44 (10), 2337-45 (in press)
DOI 10.2337/dc21-0447, PubMed 34407960

Publications 2020

Birkeland E, Gharagozlian S, Birkeland KI, Valeur J, Måge I, Rud I, Aas AM (2020)
Prebiotic effect of inulin-type fructans on faecal microbiota and short-chain fatty acids in type 2 diabetes: a randomised controlled trial
Eur J Nutr, 59 (7), 3325-3338
DOI 10.1007/s00394-020-02282-5, PubMed 32440730

Birkeland E, Gharagozlian S, Birkeland KI, Valeur J, Måge I, Rud I, Aas AM (2020)
Correction to: Prebiotic effect of inulin‑type fructans on faecal microbiota and short‑chain fatty acids in type 2 diabetes: a randomised controlled trial
Eur J Nutr, 59 (7), 3339-3340
DOI 10.1007/s00394-020-02314-0, PubMed 32632657

Birkeland KI (2020)
Some Lessons Learned About Diabetes and COVID-19 During the Early Stage of the Epidemic in Norway
J Diabetes Sci Technol, 14 (4), 718-719
DOI 10.1177/1932296820929371, PubMed 32456527

Birkeland KI, Bodegard J, Banerjee A, Kim DJ, Norhammar A, Eriksson JW, Thuresson M, Okami S, Ha KH, Kossack N, Mamza JB, Zhang R, Yajima T, Komuro I, Kadowaki T (2020)
Lower cardiorenal risk with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study
Diabetes Obes Metab, 23 (1), 75-85
DOI 10.1111/dom.14189, PubMed 32893440

Birkeland KI, Bodegard J, Eriksson JW, Norhammar A, Haller H, Linssen GCM, Banerjee A, Thuresson M, Okami S, Garal-Pantaler E, Overbeek J, Mamza JB, Zhang R, Yajima T, Komuro I, Kadowaki T (2020)
Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study
Diabetes Obes Metab, 22 (9), 1607-1618
DOI 10.1111/dom.14074, PubMed 32363737

Hansen AMB, Wium C, Lee S, Tierney AC, McCarthy D, Roche HM, Drevon CA, Birkeland KI, Gulseth HL (2020)
Substantial inter-individual variations in insulin secretion and sensitivity across the glucometabolic spectrum
Scand J Clin Lab Invest, 80 (4), 282-290
DOI 10.1080/00365513.2020.1730433, PubMed 32134347

Haugen AJ, Hallan S, Langberg NE, Dahle DO, Pihlstrøm H, Birkeland KI, Reisaeter A, Midtvedt K, Hartmann A, Holdaas H, Mjøen G (2020)
Increased long-term risk for hypertension in kidney donors - a retrospective cohort study
Transpl Int, 33 (5), 536-543
DOI 10.1111/tri.13576, PubMed 31958170

Hjelmesæth J, Fatima F, Birkeland KI, Svanevik M, Hofsø D (2020)
Metabolic surgery: one size fits all? - Authors' reply
Lancet Diabetes Endocrinol, 8 (4), 273
DOI 10.1016/S2213-8587(20)30027-9, PubMed 32059787

Knudsen ST, Bodegård J, Birkeland KI, Furuseth K, Thuresson M, Lindh A, Nilsson PM, Alvarsson M, Jørgensen ME, Søndergaard J, Persson F (2020)
Risk factor management of type 2 diabetic patients in primary care in the Scandinavian countries between 2003 and 2015
Prim Care Diabetes, 15 (2), 262-268
DOI 10.1016/j.pcd.2020.09.006, PubMed 33032936

Kohsaka S, Lam CSP, Kim DJ, Cavender MA, Norhammar A, Jørgensen ME, Birkeland KI, Holl RW, Franch-Nadal J, Tangri N, Shaw JE, Ilomäki J, Karasik A, Goh SY, Chiang CE, Thuresson M, Chen H, Wittbrodt E, Bodegård J, Surmont F, Fenici P, Kosiborod M, CVD-REAL 2 Investigators and Study Group (2020)
Risk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors: an analysis from the CVD-REAL 2 multinational cohort study
Lancet Diabetes Endocrinol, 8 (7), 606-615
DOI 10.1016/S2213-8587(20)30130-3, PubMed 32559476

Lee S, Gulseth HL, Langleite TM, Norheim F, Olsen T, Refsum H, Jensen J, Birkeland KI, Drevon CA (2020)
Branched-chain amino acid metabolism, insulin sensitivity and liver fat response to exercise training in sedentary dysglycaemic and normoglycaemic men
Diabetologia, 64 (2), 410-423
DOI 10.1007/s00125-020-05296-0, PubMed 33123769

Moen GH, Brumpton B, Willer C, Åsvold BO, Birkeland KI, Wang G, Neale MC, Freathy RM, Smith GD, Lawlor DA, Kirkpatrick RM, Warrington NM, Evans DM (2020)
Mendelian randomization study of maternal influences on birthweight and future cardiometabolic risk in the HUNT cohort
Nat Commun, 11 (1), 5404
DOI 10.1038/s41467-020-19257-z, PubMed 33106479

Nordheim E, Dahle DO, Halden T, Birkeland KI, Åsberg A, Hartmann A, Horneland R, Jenssen TG (2020)
Endothelial function after pancreas transplantation-A single-center observational study
Clin Transplant, 34 (3), e13815
DOI 10.1111/ctr.13815, PubMed 32027399

Opsahl JO, Moen GH, Qvigstad E, Böttcher Y, Birkeland KI, Sommer C (2020)
Epigenetic signatures associated with maternal body mass index or gestational weight gain: a systematic review
J Dev Orig Health Dis, 12 (3), 373-383
DOI 10.1017/S2040174420000811, PubMed 32873364

Stene LC, Ruiz PL, Åsvold BO, Bjarkø VV, Sørgjerd EP, Njølstad I, Hopstock LA, Birkeland KI, Gulseth HL (2020)
[How many people have diabetes in Norway in 2020?]
Tidsskr Nor Laegeforen, 140 (17)
DOI 10.4045/tidsskr.20.0849, PubMed 33231389

Stene LC, Ruiz PL, Åsvold BO, Bjarkø VV, Sørgjerd EP, Njølstad I, Hopstock LA, Birkeland KI, Gulseth HL (2020)
[Correction: How many people have diabetes in Norway in 2020?]
Tidsskr Nor Laegeforen, 140 (18)
DOI 10.4045/tidsskr.20.0928, PubMed 33322883

Stene LC, Ruiz PLD, Asvold BO, Bjarko VV, Sorgjerd EP, Njolstad I, Hopstock LA, Birkeland KI, Gulseth HL (2020)
How many people have diabetes in Norway in 2020?
Tidsskr. Nor. Laegeforen., 140 (17), 1750-1753

Publications 2019

Arora S, Ofstad AP, Ulimoen GR, Birkeland KI, Endresen K, Gullestad L, Johansen OE (2019)
Asymptomatic coronary artery disease in a Norwegian cohort with type 2 diabetes: a prospective angiographic study with intravascular ultrasound evaluation
Cardiovasc Diabetol, 18 (1), 26
DOI 10.1186/s12933-019-0832-2, PubMed 30851727

Birkeland KI, Bodegard J, Norhammar A, Kuiper JG, Georgiado E, Beekman-Hendriks WL, Thuresson M, Pignot M, Herings RMC, Kooy A (2019)
How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study
Diabetes Obes Metab, 21 (4), 968-974
DOI 10.1111/dom.13612, PubMed 30537226

Borgeraas H, Hjelmesæth J, Birkeland KI, Fatima F, Grimnes JO, Gulseth HL, Halvorsen E, Hertel JK, Hillestad TOW, Johnson LK, Karlsen TI, Kolotkin RL, Kvan NP, Lindberg M, Lorentzen J, Nordstrand N, Sandbu R, Seeberg KA, Seip B, Svanevik M, Valderhaug TG, Hofsø D (2019)
Single-centre, triple-blinded, randomised, 1-year, parallel-group, superiority study to compare the effects of Roux-en-Y gastric bypass and sleeve gastrectomy on remission of type 2 diabetes and β-cell function in subjects with morbid obesity: a protocol for the Obesity surgery in Tønsberg (Oseberg) study
BMJ Open, 9 (6), e024573
DOI 10.1136/bmjopen-2018-024573, PubMed 31167860

Elvebakk O, Tronstad C, Birkeland KI, Jenssen TG, Bjørgaas MR, Frøslie KF, Godang K, Kalvøy H, Martinsen ØG, Gulseth HL (2019)
Author Correction: Evaluation of Hypoglycaemia with Non-Invasive Sensors in People with Type 1 Diabetes and Impaired Awareness of Hypoglycaemia
Sci Rep, 9 (1), 6347
DOI 10.1038/s41598-019-42218-6, PubMed 30988313

Elvebakk O, Tronstad C, Birkeland KI, Jenssen TG, Bjørgaas MR, Gulseth HL, Kalvøy H, Høgetveit JO, Martinsen ØG (2019)
A multiparameter model for non-invasive detection of hypoglycemia
Physiol Meas, 40 (8), 085004
DOI 10.1088/1361-6579/ab3676, PubMed 31357185

Gulseth HL, Gjelstad IMF, Tiereny AC, McCarthy D, Lovegrove JA, Defoort C, Blaak EE, Lopez-Miranda J, Dembinska-Kiec A, Risérus U, Roche HM, Drevon CA, Birkeland KI (2019)
Effects of dietary fat on insulin secretion in subjects with the metabolic syndrome
Eur J Endocrinol, 180 (5), 321-328
DOI 10.1530/EJE-19-0022, PubMed 30893645

Haugen AJ, Langberg NE, Dahle DO, Pihlstrøm H, Birkeland KI, Reisaeter A, Midtvedt K, Hartmann A, Holdaas H, Mjøen G (2019)
Long-term risk for kidney donors with hypertension at donation - a retrospective cohort study
Transpl Int, 32 (9), 960-964
DOI 10.1111/tri.13443, PubMed 30983060

Hofsø D, Fatima F, Borgeraas H, Birkeland KI, Gulseth HL, Hertel JK, Johnson LK, Lindberg M, Nordstrand N, Cvancarova Småstuen M, Stefanovski D, Svanevik M, Gretland Valderhaug T, Sandbu R, Hjelmesæth J (2019)
Gastric bypass versus sleeve gastrectomy in patients with type 2 diabetes (Oseberg): a single-centre, triple-blind, randomised controlled trial
Lancet Diabetes Endocrinol, 7 (12), 912-924
DOI 10.1016/S2213-8587(19)30344-4, PubMed 31678062

Lee S, Kolset SO, Birkeland KI, Drevon CA, Reine TM (2019)
Acute exercise increases syndecan-1 and -4 serum concentrations
Glycoconj J, 36 (2), 113-125
DOI 10.1007/s10719-019-09869-z, PubMed 30949875

Lee S, Norheim F, Langleite TM, Gulseth HL, Birkeland KI, Drevon CA (2019)
Effects of long-term exercise on plasma adipokine levels and inflammation-related gene expression in subcutaneous adipose tissue in sedentary dysglycaemic, overweight men and sedentary normoglycaemic men of healthy weight
Diabetologia, 62 (6), 1048-1064
DOI 10.1007/s00125-019-4866-5, PubMed 31011777

Ofstad AP, Sommer C, Birkeland KI, Bjørgaas MR, Gran JM, Gulseth HL, Johansen OE (2019)
Comparison of the associations between non-traditional and traditional indices of adiposity and cardiovascular mortality: an observational study of one million person-years of follow-up
Int J Obes (Lond), 43 (5), 1082-1092
DOI 10.1038/s41366-019-0353-9, PubMed 30926954

Ruiz PLD, Bakken IJ, Håberg SE, Tapia G, Hauge SH, Birkeland KI, Gulseth HL, Stene LC (2019)
Higher frequency of hospitalization but lower relative mortality for pandemic influenza in people with type 2 diabetes
J Intern Med, 287 (1), 78-86
DOI 10.1111/joim.12984, PubMed 31587396

Vedal TSJ, Steen NE, Birkeland KI, Dieset I, Reponen EJ, Laskemoen JF, Rødevand L, Melle I, Andreassen OA, Molden E, Jönsson EG (2019)
Adipokine levels are associated with insulin resistance in antipsychotics users independently of BMI
Psychoneuroendocrinology, 103, 87-95
DOI 10.1016/j.psyneuen.2019.01.001, PubMed 30659986

Publications 2018

Baerug A, Sletner L, Laake P, Fretheim A, Løland BF, Waage CW, Birkeland KI, Jenum AK (2018)
Recent gestational diabetes was associated with mothers stopping predominant breastfeeding earlier in a multi-ethnic population
Acta Paediatr, 107 (6), 1028-1035
DOI 10.1111/apa.14274, PubMed 29432660

Birkeland K (2018)
THE MASTERY OF LIFE WITH DIABETES Type I
Tidsskr. Nor. Laegeforen., 138 (18), 1767

Birkeland KI, Grill V, Wium C, McQueen MJ, Lopez-Jaramillo P, Lee SF, Gerstein HC (2018)
The association of basal insulin treatment versus standard care with outcomes in anti-GAD positive and negative subjects: A post-hoc analysis of the ORIGIN trial
Diabetes Obes Metab, 21 (2), 429-433
DOI 10.1111/dom.13528, PubMed 30203580

Cavender MA, Norhammar A, Birkeland KI, Jørgensen ME, Wilding JP, Khunti K, Fu AZ, Bodegård J, Blak BT, Wittbrodt E, Thuresson M, Fenici P, Hammar N, Kosiborod M, CVD-REAL Investigators and Study Group (2018)
SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL
J Am Coll Cardiol, 71 (22), 2497-2506
DOI 10.1016/j.jacc.2018.01.085, PubMed 29852973

Davies TT, Graue M, Igland J, Tell GS, Birkeland KI, Peyrot M, Haltbakk J (2018)
Diabetes prevalence among older people receiving care at home: associations with symptoms, health status and psychological well-being
Diabet Med, 36 (1), 96-104
DOI 10.1111/dme.13790, PubMed 30062788

Eggemoen ÅR, Waage CW, Sletner L, Gulseth HL, Birkeland KI, Jenum AK (2018)
Vitamin D, Gestational Diabetes, and Measures of Glucose Metabolism in a Population-Based Multiethnic Cohort
J Diabetes Res, 2018, 8939235
DOI 10.1155/2018/8939235, PubMed 29850611

Elvebakk O, Tronstad C, Birkeland KI, Jenssen TG, Bjørgaas MR, Frøslie KF, Godang K, Kalvøy H, Martinsen ØG, Gulseth HL (2018)
Evaluation of Hypoglycaemia with Non-Invasive Sensors in People with Type 1 Diabetes and Impaired Awareness of Hypoglycaemia
Sci Rep, 8 (1), 14722
DOI 10.1038/s41598-018-33189-1, PubMed 30283093

Heier M, Ofstad AP, Borja MS, Brunborg C, Endresen K, Gullestad L, Birkeland KI, Johansen OE, Oda MN (2018)
High-density lipoprotein function is associated with atherosclerotic burden and cardiovascular outcomes in type 2 diabetes
Atherosclerosis, 282, 183-187
DOI 10.1016/j.atherosclerosis.2018.07.005, PubMed 30017177

Kosiborod M, Birkeland KI, Cavender MA, Fu AZ, Wilding JP, Khunti K, Holl RW, Norhammar A, Jørgensen ME, Wittbrodt ET, Thuresson M, Bodegård J, Hammar N, Fenici P, CVD-REAL Investigators and Study Group (2018)
Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2-inhibitors versus other glucose-lowering agents in real-world clinical practice: Results from the CVD-REAL study
Diabetes Obes Metab, 20 (8), 1983-1987
DOI 10.1111/dom.13299, PubMed 29569378

Kosiborod M, Cavender MA, Fu AZ, Wilding JP, Khunti K, Holl RW, Norhammar A, Birkeland KI, Jørgensen ME, Thuresson M, Arya N, Bodegård J, Hammar N, Fenici P, CVD-REAL Investigators and Study Group (2018)
Response by Kosiborod et al to Letters Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)"
Circulation, 137 (9), 989-991
DOI 10.1161/CIRCULATIONAHA.117.031847, PubMed 29483180

Lee S, Norheim F, Gulseth HL, Langleite TM, Aker A, Gundersen TE, Holen T, Birkeland KI, Drevon CA (2018)
Skeletal muscle phosphatidylcholine and phosphatidylethanolamine respond to exercise and influence insulin sensitivity in men
Sci Rep, 8 (1), 6531
DOI 10.1038/s41598-018-24976-x, PubMed 29695812

Lee S, Norheim F, Gulseth HL, Langleite TM, Aker A, Gundersen TE, Holen T, Birkeland KI, Drevon CA (2018)
Author Correction: Skeletal muscle phosphatidylcholine and phosphatidylethanolamine respond to exercise and influence insulin sensitivity in men
Sci Rep, 8 (1), 7885
DOI 10.1038/s41598-018-26061-9, PubMed 29760520

Lee S, Olsen T, Vinknes KJ, Refsum H, Gulseth HL, Birkeland KI, Drevon CA (2018)
Plasma Sulphur-Containing Amino Acids, Physical Exercise and Insulin Sensitivity in Overweight Dysglycemic and Normal Weight Normoglycemic Men
Nutrients, 11 (1)
DOI 10.3390/nu11010010, PubMed 30577516

Moen GH, LeBlanc M, Sommer C, Prasad RB, Lekva T, Normann KR, Qvigstad E, Groop L, Birkeland KI, Evans DM, Frøslie KF (2018)
Genetic determinants of glucose levels in pregnancy: genetic risk scores analysis and GWAS in the Norwegian STORK cohort
Eur J Endocrinol, 179 (6), 363-372
DOI 10.1530/EJE-18-0478, PubMed 30324795

Moen GH, Qvigstad E, Birkeland KI, Evans DM, Sommer C (2018)
Are serum concentrations of vitamin B-12 causally related to cardiometabolic risk factors and disease? A Mendelian randomization study
Am J Clin Nutr, 108 (2), 398-404
DOI 10.1093/ajcn/nqy101, PubMed 29982347

Nordheim E, Birkeland KI, Åsberg A, Hartmann A, Horneland R, Jenssen T (2018)
Preserved insulin secretion and kidney function in recipients with functional pancreas grafts 1 year after transplantation: a single-center prospective observational study
Eur J Endocrinol, 179 (4), 251-259
DOI 10.1530/EJE-18-0360, PubMed 30299895

Persson F, Bodegard J, Lahtela JT, Nyström T, Jørgensen ME, Jensen ML, Gulseth HL, Thuresson M, Hoti F, Nathanson D, Norhammar A, Birkeland KI, Eriksson JG, Eriksson JW (2018)
Different patterns of second-line treatment in type 2 diabetes after metformin monotherapy in Denmark, Finland, Norway and Sweden (D360 Nordic): A multinational observational study
Endocrinol Diabetes Metab, 1 (4), e00036
DOI 10.1002/edm2.36, PubMed 30815564

Riiser A, Solbraa A, Jenum AK, Birkeland KI, Andersen LB (2018)
Cycling and walking for transport and their associations with diabetes and risk factors for cardiovascular disease
J. Transp. Health, 11, 193-201
DOI 10.1016/j.jth.2018.09.002

Ruiz PLD, Stene LC, Bakken IJ, Håberg SE, Birkeland KI, Gulseth HL (2018)
Decreasing incidence of pharmacologically and non-pharmacologically treated type 2 diabetes in Norway: a nationwide study
Diabetologia, 61 (11), 2310-2318
DOI 10.1007/s00125-018-4681-4, PubMed 29995214

Sommer C, Lee S, Gulseth HL, Jensen J, Drevon CA, Birkeland KI (2018)
Soluble Leptin Receptor Predicts Insulin Sensitivity and Correlates With Upregulation of Metabolic Pathways in Men
J Clin Endocrinol Metab, 103 (3), 1024-1032
DOI 10.1210/jc.2017-02126, PubMed 29300960

Thuresson M, Cavender MA, Fu AZ, Wilding JP, Khunti K, Holl RW, Norhammar A, Birkeland KI, Jørgensen ME, Wittbrodt E, Hammar N, Fenici P, Kosiborod M, CVD-REAL Investigators and Study Group (2018)
Comment on Suissa. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6-10
Diabetes Care, 41 (6), e106-e108
DOI 10.2337/dc18-0338, PubMed 29784708

Tronstad C, Elvebakk O, Staal OM, Kalvøy H, Høgetveit JO, Jenssen TG, Birkeland KI, Martinsen ØG (2018)
Non-invasive prediction of blood glucose trends during hypoglycemia
Anal Chim Acta, 1052, 37-48
DOI 10.1016/j.aca.2018.12.009, PubMed 30685040

Vedal TSJ, Steen NE, Birkeland KI, Dieset I, Reponen EJ, Laskemoen JF, Rødevand L, Melle I, Andreassen OA, Molden E, Jönsson EG (2018)
Free thyroxine and thyroid-stimulating hormone in severe mental disorders: A naturalistic study with focus on antipsychotic medication
J Psychiatr Res, 106, 74-81
DOI 10.1016/j.jpsychires.2018.09.014, PubMed 30292780

Vedal TSJ, Steen NE, Birkeland KI, Dieset I, Reponen EJ, Laskemoen JF, Rødevand L, Melle I, Andreassen OA, Molden E, Jönsson EG (2018)
Response: Are thyroid abnormalities only related to antipsychotic treatment in patients with severe mental disorders?
J Psychiatr Res, 117, 150
DOI 10.1016/j.jpsychires.2018.11.012, PubMed 30454945

Publications 2017

Birkeland KI (2017)
[Not Available]
Tidsskr Nor Laegeforen, 137 (18)
DOI 10.4045/tidsskr.17.0774, PubMed 28972323

Birkeland KI (2017)
[Not Available]
Tidsskr Nor Laegeforen, 137 (18)
DOI 10.4045/tidsskr.17.0517, PubMed 28972339

Birkeland KI (2017)
Anti-diabetes is just a part of good diabetes treatment!
Tidsskr. Nor. Laegeforen., 137 (18), 1395-1396

Birkeland KI (2017)
TESTOSTERONE
Tidsskr. Nor. Laegeforen., 137 (18), 1453

Birkeland KI, Jørgensen ME, Carstensen B, Persson F, Gulseth HL, Thuresson M, Fenici P, Nathanson D, Nyström T, Eriksson JW, Bodegård J, Norhammar A (2017)
Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL Nordic): a multinational observational analysis
Lancet Diabetes Endocrinol, 5 (9), 709-717
DOI 10.1016/S2213-8587(17)30258-9, PubMed 28781064

Gulseth HL, Wium C, Angel K, Eriksen EF, Birkeland KI (2017)
Effects of Vitamin D Supplementation on Insulin Sensitivity and Insulin Secretion in Subjects With Type 2 Diabetes and Vitamin D Deficiency: A Randomized Controlled Trial
Diabetes Care, 40 (7), 872-878
DOI 10.2337/dc16-2302, PubMed 28468770

Görgens SW, Benninghoff T, Eckardt K, Springer C, Chadt A, Melior A, Wefers J, Cramer A, Jensen J, Birkeland KI, Drevon CA, Al-Hasani H, Eckel J (2017)
Hypoxia in Combination With Muscle Contraction Improves Insulin Action and Glucose Metabolism in Human Skeletal Muscle via the HIF-1α Pathway
Diabetes, 66 (11), 2800-2807
DOI 10.2337/db16-1488, PubMed 28811274

Jenssen T, Hartmann A, Birkeland KI (2017)
Long-term diabetes complications after pancreas transplantation
Curr Opin Organ Transplant, 22 (4), 382-388
DOI 10.1097/MOT.0000000000000436, PubMed 28598888

Kosiborod M, Cavender MA, Fu AZ, Wilding JP, Khunti K, Holl RW, Norhammar A, Birkeland KI, Jørgensen ME, Thuresson M, Arya N, Bodegård J, Hammar N, Fenici P, CVD-REAL Investigators and Study Group* (2017)
Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)
Circulation, 136 (3), 249-259
DOI 10.1161/CIRCULATIONAHA.117.029190, PubMed 28522450

Lee S, Norheim F, Gulseth HL, Langleite TM, Kolnes KJ, Tangen DS, Stadheim HK, Gilfillan GD, Holen T, Birkeland KI, Jensen J, Drevon CA (2017)
Interaction between plasma fetuin-A and free fatty acids predicts changes in insulin sensitivity in response to long-term exercise
Physiol Rep, 5 (5)
DOI 10.14814/phy2.13183, PubMed 28270597

Lund J, Rustan AC, Løvsletten NG, Mudry JM, Langleite TM, Feng YZ, Stensrud C, Brubak MG, Drevon CA, Birkeland KI, Kolnes KJ, Johansen EI, Tangen DS, Stadheim HK, Gulseth HL, Krook A, Kase ET, Jensen J, Thoresen GH (2017)
Exercise in vivo marks human myotubes in vitro: Training-induced increase in lipid metabolism
PLoS One, 12 (4), e0175441
DOI 10.1371/journal.pone.0175441, PubMed 28403174

Moen GH, Sommer C, Prasad RB, Sletner L, Groop L, Qvigstad E, Birkeland KI (2017)
MECHANISMS IN ENDOCRINOLOGY: Epigenetic modifications and gestational diabetes: a systematic review of published literature
Eur J Endocrinol, 176 (5), R247-R267
DOI 10.1530/EJE-16-1017, PubMed 28232369

Ofstad AP, Ulimoen GR, Orvik E, Birkeland KI, Gullestad LL, Fagerland MW, Johansen OE (2017)
Long-term follow-up of a hospital-based, multi-intervention programme in type 2 diabetes mellitus: impact on cardiovascular events and death
J Int Med Res, 45 (5), 1535-1552
DOI 10.1177/0300060517707674, PubMed 28627980

Persson F, Nyström T, Jørgensen ME, Carstensen B, Gulseth HL, Thuresson M, Fenici P, Nathanson D, Eriksson JW, Norhammar A, Bodegard J, Birkeland KI (2017)
Dapagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in people with type 2 diabetes (CVD-REAL Nordic) when compared with dipeptidyl peptidase-4 inhibitor therapy: A multinational observational study
Diabetes Obes Metab, 20 (2), 344-351
DOI 10.1111/dom.13077, PubMed 28771923

Pourteymour S, Eckardt K, Holen T, Langleite T, Lee S, Jensen J, Birkeland KI, Drevon CA, Hjorth M (2017)
Global mRNA sequencing of human skeletal muscle: Search for novel exercise-regulated myokines
Mol Metab, 6 (4), 352-365
DOI 10.1016/j.molmet.2017.01.007, PubMed 28377874

Pourteymour S, Hjorth M, Lee S, Holen T, Langleite TM, Jensen J, Birkeland KI, Drevon CA, Eckardt K (2017)
Dual specificity phosphatase 5 and 6 are oppositely regulated in human skeletal muscle by acute exercise
Physiol Rep, 5 (19)
DOI 10.14814/phy2.13459, PubMed 28989118

Risstad H, Kristinsson JA, Fagerland MW, le Roux CW, Birkeland KI, Gulseth HL, Thorsby PM, Vincent RP, Engström M, Olbers T, Mala T (2017)
Bile acid profiles over 5 years after gastric bypass and duodenal switch: results from a randomized clinical trial
Surg Obes Relat Dis, 13 (9), 1544-1553
DOI 10.1016/j.soard.2017.05.024, PubMed 28756050

Sletner L, Jenum AK, Yajnik CS, Mørkrid K, Nakstad B, Rognerud-Jensen OH, Birkeland KI, Vangen S (2017)
Fetal growth trajectories in pregnancies of European and South Asian mothers with and without gestational diabetes, a population-based cohort study
PLoS One, 12 (3), e0172946
DOI 10.1371/journal.pone.0172946, PubMed 28253366

Publications 2016

Eggemoen ÅR, Falk RS, Knutsen KV, Lagerløv P, Sletner L, Birkeland KI, Jenum AK (2016)
Vitamin D deficiency and supplementation in pregnancy in a multiethnic population-based cohort
BMC Pregnancy Childbirth, 16, 7
DOI 10.1186/s12884-016-0796-0, PubMed 26785795

Langleite TM, Jensen J, Norheim F, Gulseth HL, Tangen DS, Kolnes KJ, Heck A, Storås T, Grøthe G, Dahl MA, Kielland A, Holen T, Noreng HJ, Stadheim HK, Bjørnerud A, Johansen EI, Nellemann B, Birkeland KI, Drevon CA (2016)
Insulin sensitivity, body composition and adipose depots following 12 w combined endurance and strength training in dysglycemic and normoglycemic sedentary men
Arch Physiol Biochem, 122 (4), 167-179
DOI 10.1080/13813455.2016.1202985, PubMed 27477619

Lee S, Norheim F, Langleite TM, Noreng HJ, Storås TH, Afman LA, Frost G, Bell JD, Thomas EL, Kolnes KJ, Tangen DS, Stadheim HK, Gilfillan GD, Gulseth HL, Birkeland KI, Jensen J, Drevon CA, Holen T, NutriTech Consortium (2016)
Effect of energy restriction and physical exercise intervention on phenotypic flexibility as examined by transcriptomics analyses of mRNA from adipose tissue and whole body magnetic resonance imaging
Physiol Rep, 4 (21)
DOI 10.14814/phy2.13019, PubMed 27821717

Sommer C, Gulseth HL, Jenum AK, Sletner L, Thorsby PM, Birkeland KI (2016)
Soluble Leptin Receptor and Risk of Gestational Diabetes in a Multiethnic Population: A Prospective Cohort Study
J Clin Endocrinol Metab, 101 (11), 4070-4075
DOI 10.1210/jc.2016-2583, PubMed 27537771

Waage C, Jenum AK, Mdala I, Berg JP, Richardsen K, Birkeland K (2016)
Associations between gestational diabetes mellitus and elevated HbA_1c early postpartum in a multi-ethnic population
Prim Care Diabetes, 11 (2), 132-139
DOI 10.1016/j.pcd.2016.09.007, PubMed 27771271

Waage CW, Mdala I, Jenum AK, Michelsen TM, Birkeland KI, Sletner L (2016)
Ethnic differences in blood pressure from early pregnancy to postpartum: a Norwegian cohort study
J Hypertens, 34 (6), 1151-9
DOI 10.1097/HJH.0000000000000918, PubMed 27088633

Publications 2015

Birkeland KI (2015)
Hyperglycaemia in pregnancy: still a lot to learn
Lancet Diabetes Endocrinol, 3 (10), 752-3
DOI 10.1016/S2213-8587(15)00282-X, PubMed 26355009

Birkeland KI (2015)
Hypoglycaemia in clinical diabetes
Tidsskr. Nor. Laegeforen., 135 (9), 876
DOI 10.4045/tidsskr.15.0222

Görgens SW, Hjorth M, Eckardt K, Wichert S, Norheim F, Holen T, Lee S, Langleite T, Birkeland KI, Stadheim HK, Kolnes KJ, Tangen DS, Kolnes AJ, Jensen J, Drevon CA, Eckel J (2015)
The exercise-regulated myokine chitinase-3-like protein 1 stimulates human myocyte proliferation
Acta Physiol (Oxf), 216 (3), 330-45
DOI 10.1111/apha.12579, PubMed 26303257

Hjorth M, Norheim F, Meen AJ, Pourteymour S, Lee S, Holen T, Jensen J, Birkeland KI, Martinov VN, Langleite TM, Eckardt K, Drevon CA, Kolset SO (2015)
The effect of acute and long-term physical activity on extracellular matrix and serglycin in human skeletal muscle
Physiol Rep, 3 (8)
DOI 10.14814/phy2.12473, PubMed 26290530

Hjorth M, Pourteymour S, Görgens SW, Langleite TM, Lee S, Holen T, Gulseth HL, Birkeland KI, Jensen J, Drevon CA, Norheim F (2015)
Myostatin in relation to physical activity and dysglycaemia and its effect on energy metabolism in human skeletal muscle cells
Acta Physiol (Oxf), 217 (1), 45-60
DOI 10.1111/apha.12631, PubMed 26572800

Hofsø D, Birkeland KI, Holst JJ, Bollerslev J, Sandbu R, Røislien J, Hjelmesæth J (2015)
Gastric bypass surgery has a weight-loss independent effect on post-challenge serum glucose levels
Diabetol Metab Syndr, 7, 69
DOI 10.1186/s13098-015-0066-8, PubMed 26300987

Ofstad AP, Urheim S, Dalen H, Orvik E, Birkeland KI, Gullestad L, W Fagerland M, Johansen OE, Aakhus S (2015)
Identification of a definite diabetic cardiomyopathy in type 2 diabetes by comprehensive echocardiographic evaluation: A cross-sectional comparison with non-diabetic weight-matched controls
J Diabetes, 7 (6), 779-90
DOI 10.1111/1753-0407.12239, PubMed 25350248

Pourteymour S, Lee S, Langleite TM, Eckardt K, Hjorth M, Bindesbøll C, Dalen KT, Birkeland KI, Drevon CA, Holen T, Norheim F (2015)
Perilipin 4 in human skeletal muscle: localization and effect of physical activity
Physiol Rep, 3 (8)
DOI 10.14814/phy2.12481, PubMed 26265748

Risstad H, Søvik TT, Engström M, Aasheim ET, Fagerland MW, Olsén MF, Kristinsson JA, le Roux CW, Bøhmer T, Birkeland KI, Mala T, Olbers T (2015)
Five-year outcomes after laparoscopic gastric bypass and laparoscopic duodenal switch in patients with body mass index of 50 to 60: a randomized clinical trial
JAMA Surg, 150 (4), 352-61
DOI 10.1001/jamasurg.2014.3579, PubMed 25650964

Sommer C, Jenum AK, Waage CW, Mørkrid K, Sletner L, Birkeland KI (2015)
Ethnic differences in BMI, subcutaneous fat, and serum leptin levels during and after pregnancy and risk of gestational diabetes
Eur J Endocrinol, 172 (6), 649-56
DOI 10.1530/EJE-15-0060, PubMed 25740849

Sommer C, Sletner L, Mørkrid K, Jenum AK, Birkeland KI (2015)
Effects of early pregnancy BMI, mid-gestational weight gain, glucose and lipid levels in pregnancy on offspring's birth weight and subcutaneous fat: a population-based cohort study
BMC Pregnancy Childbirth, 15, 84
DOI 10.1186/s12884-015-0512-5, PubMed 25879215

Waage CW, Falk RS, Sommer C, Mørkrid K, Richardsen KR, Baerug A, Shakeel N, Birkeland KI, Jenum AK (2015)
Ethnic differences in postpartum weight retention: a Norwegian cohort study
BJOG, 123 (5), 699-708
DOI 10.1111/1471-0528.13321, PubMed 25716276

Publications 2014

Birkeland KI (2014)
[How is the quality of the diabetes care?]
Tidsskr Nor Laegeforen, 134 (2), 133
DOI 10.4045/tidsskr.13.1435, PubMed 24477123

Bordeleau L, Yakubovich N, Dagenais GR, Rosenstock J, Probstfield J, Chang Yu P, Ryden LE, Pirags V, Spinas GA, Birkeland KI, Ratner RE, Marin-Neto JA, Keltai M, Riddle MC, Bosch J, Yusuf S, Gerstein HC, ORIGIN Trial Investigators (2014)
The association of basal insulin glargine and/or n-3 fatty acids with incident cancers in patients with dysglycemia
Diabetes Care, 37 (5), 1360-6
DOI 10.2337/dc13-1468, PubMed 24574355

Gulseth HL, Risstad H, Birkeland KI (2014)
Bariatric surgery versus intensive medical therapy for diabetes
N Engl J Med, 371 (7), 681
DOI 10.1056/NEJMc1407393, PubMed 25119618

Li Y, Lee S, Langleite T, Norheim F, Pourteymour S, Jensen J, Stadheim HK, Storås TH, Davanger S, Gulseth HL, Birkeland KI, Drevon CA, Holen T (2014)
Subsarcolemmal lipid droplet responses to a combined endurance and strength exercise intervention
Physiol Rep, 2 (11)
DOI 10.14814/phy2.12187, PubMed 25413318

Mørkrid K, Jenum AK, Berntsen S, Sletner L, Richardsen KR, Vangen S, Holme I, Birkeland KI (2014)
Objectively recorded physical activity and the association with gestational diabetes
Scand J Med Sci Sports, 24 (5), e389-97
DOI 10.1111/sms.12183, PubMed 24894027

Norheim F, Hjorth M, Langleite TM, Lee S, Holen T, Bindesbøll C, Stadheim HK, Gulseth HL, Birkeland KI, Kielland A, Jensen J, Dalen KT, Drevon CA (2014)
Regulation of angiopoietin-like protein 4 production during and after exercise
Physiol Rep, 2 (8)
DOI 10.14814/phy2.12109, PubMed 25138789

Ofstad AP, Johansen OE, Gullestad L, Birkeland KI, Orvik E, Fagerland MW, Urheim S, Aakhus S (2014)
Neutral impact on systolic and diastolic cardiac function of 2 years of intensified multi-intervention in type 2 diabetes: the randomized controlled Asker and Bærum Cardiovascular Diabetes (ABCD) study
Am Heart J, 168 (3), 280-288.e2
DOI 10.1016/j.ahj.2014.03.026, PubMed 25173538

Sachse D, Bærug A, Sletner L, Birkeland KI, Nakstad B, Jenum AK, Berg JP (2014)
Urine NMR metabolomics analysis of breastfeeding biomarkers during and after pregnancy in a large prospective cohort study
Scand J Clin Lab Invest, 74 (3), 264-72
DOI 10.3109/00365513.2014.884240, PubMed 24621206

Sletner L, Jenum AK, Mørkrid K, Vangen S, Holme IM, Birkeland KI, Nakstad B (2014)
Maternal life course socio-economic position and offspring body composition at birth in a multi-ethnic population
Paediatr Perinat Epidemiol, 28 (5), 445-54
DOI 10.1111/ppe.12137, PubMed 25060595

Strøm H, Selmer R, Birkeland KI, Schirmer H, Berg TJ, Jenum AK, Midthjell K, Berg C, Stene LC (2014)
No increase in new users of blood glucose-lowering drugs in Norway 2006-2011: a nationwide prescription database study
BMC Public Health, 14, 520
DOI 10.1186/1471-2458-14-520, PubMed 24886413

Wium C, Eggesbø HB, Ueland T, Michelsen AE, Torjesen PA, Aukrust P, Birkeland K (2014)
Adipose tissue distribution in relation to insulin sensitivity and inflammation in Pakistani and Norwegian subjects with type 2 diabetes
Scand J Clin Lab Invest, 74 (8), 700-7
DOI 10.3109/00365513.2014.953571, PubMed 25223599

Publications 2013

Gulseth HL, Gjelstad IM, Birkeland KI, Drevon CA (2013)
Vitamin D and the metabolic syndrome
Curr Vasc Pharmacol, 11 (6), 968-84
DOI 10.2174/15701611113119990169, PubMed 24168438

Meneghini L, Atkin SL, Gough SC, Raz I, Blonde L, Shestakova M, Bain S, Johansen T, Begtrup K, Birkeland KI, NN1250-3668 (BEGIN FLEX) Trial Investigators (2013)
The efficacy and safety of insulin degludec given in variable once-daily dosing intervals compared with insulin glargine and insulin degludec dosed at the same time daily: a 26-week, randomized, open-label, parallel-group, treat-to-target trial in individuals with type 2 diabetes
Diabetes Care, 36 (4), 858-64
DOI 10.2337/dc12-1668, PubMed 23340894

Norheim F, Langleite TM, Hjorth M, Holen T, Kielland A, Stadheim HK, Gulseth HL, Birkeland KI, Jensen J, Drevon CA (2013)
The effects of acute and chronic exercise on PGC-1α, irisin and browning of subcutaneous adipose tissue in humans
FEBS J, 281 (3), 739-49
DOI 10.1111/febs.12619, PubMed 24237962

Ofstad AP, Gullestad L, Orvik E, Aakhus S, Endresen K, Ueland T, Aukrust P, Fagerland MW, Birkeland KI, Johansen OE (2013)
Interleukin-6 and activin A are independently associated with cardiovascular events and mortality in type 2 diabetes: the prospective Asker and Bærum Cardiovascular Diabetes (ABCD) cohort study
Cardiovasc Diabetol, 12, 126
DOI 10.1186/1475-2840-12-126, PubMed 23987834

Sletner L, Nakstad B, Yajnik CS, Mørkrid K, Vangen S, Vårdal MH, Holme IM, Birkeland KI, Jenum AK (2013)
Ethnic differences in neonatal body composition in a multi-ethnic population and the impact of parental factors: a population-based cohort study
PLoS One, 8 (8), e73058
DOI 10.1371/journal.pone.0073058, PubMed 24009731

Sommer C, Mørkrid K, Jenum AK, Sletner L, Mosdøl A, Birkeland KI (2013)
Weight gain, total fat gain and regional fat gain during pregnancy and the association with gestational diabetes: a population-based cohort study
Int J Obes (Lond), 38 (1), 76-81
DOI 10.1038/ijo.2013.185, PubMed 24051503

Sommer C, Sletner L, Jenum AK, Mørkrid K, Andersen LF, Birkeland KI, Mosdøl A (2013)
Ethnic differences in maternal dietary patterns are largely explained by socio-economic score and integration score: a population-based study
Food Nutr Res, 57
DOI 10.3402/fnr.v57i0.21164, PubMed 23843779

Tran AT, Straand J, Dalen I, Birkeland KI, Claudi T, Cooper JG, Meyer HE, Jenum AK (2013)
Pharmacological primary and secondary cardiovascular prevention among diabetic patients in a multiethnic general practice population: still room for improvements
BMC Health Serv Res, 13, 182
DOI 10.1186/1472-6963-13-182, PubMed 23688317

Wium C, Gulseth HL, Eriksen EF, Birkeland KI (2013)
Characteristics of glucose metabolism in Nordic and South Asian subjects with type 2 diabetes
PLoS One, 8 (12), e83983
DOI 10.1371/journal.pone.0083983, PubMed 24391858

Wium C, Aasheim ET, Ueland T, Michelsen AE, Thorsby PM, Larsen IF, Torjesen PA, Aukrust P, Birkeland KI (2013)
Differences in insulin sensitivity, lipid metabolism and inflammation between young adult Pakistani and Norwegian patients with type 2 diabetes: a cross sectional study
BMC Endocr Disord, 13, 49
DOI 10.1186/1472-6823-13-49, PubMed 24148878

Publications 2012

Berntsen S, Richardsen KR, Mørkrid K, Sletner L, Birkeland KI, Jenum AK (2012)
Objectively recorded physical activity in early pregnancy: a multiethnic population-based study
Scand J Med Sci Sports, 24 (3), 594-601
DOI 10.1111/sms.12034, PubMed 23278771

Birkeland KI (2012)
[Early insulin therapy in type 2 diabetes?]
Tidsskr Nor Laegeforen, 132 (19), 2151-2
DOI 10.4045/tidsskr.12.0866, PubMed 23076480

Home PD, Meneghini L, Wendisch U, Ratner RE, Johansen T, Christensen TE, Jendle J, Roberts AP, Birkeland KI (2012)
Improved health status with insulin degludec compared with insulin glargine in people with type 1 diabetes
Diabet Med, 29 (6), 716-20
DOI 10.1111/j.1464-5491.2011.03547.x, PubMed 22150786

Jenum AK, Diep LM, Holmboe-Ottesen G, Holme IM, Kumar BN, Birkeland KI (2012)
Diabetes susceptibility in ethnic minority groups from Turkey, Vietnam, Sri Lanka and Pakistan compared with Norwegians - the association with adiposity is strongest for ethnic minority women
BMC Public Health, 12, 150
DOI 10.1186/1471-2458-12-150, PubMed 22380873

Mørkrid K, Jenum AK, Sletner L, Vårdal MH, Waage CW, Nakstad B, Vangen S, Birkeland KI (2012)
Failure to increase insulin secretory capacity during pregnancy-induced insulin resistance is associated with ethnicity and gestational diabetes
Eur J Endocrinol, 167 (4), 579-88
DOI 10.1530/EJE-12-0452, PubMed 22889687

Sachse D, Sletner L, Mørkrid K, Jenum AK, Birkeland KI, Rise F, Piehler AP, Berg JP (2012)
Metabolic changes in urine during and after pregnancy in a large, multiethnic population-based cohort study of gestational diabetes
PLoS One, 7 (12), e52399
DOI 10.1371/journal.pone.0052399, PubMed 23285025

Telle-Hjellset V, Råberg Kjøllesdal MK, Bjørge B, Holmboe-Ottesen G, Wandel M, Birkeland KI, Eriksen HR, Høstmark AT (2012)
The InnvaDiab-DE-PLAN study: a randomised controlled trial with a culturally adapted education programme improved the risk profile for type 2 diabetes in Pakistani immigrant women
Br J Nutr, 109 (3), 529-38
DOI 10.1017/S000711451200133X, PubMed 22717286

Ueland T, Aukrust P, Aakhus S, Smith C, Endresen K, Birkeland KI, Gullestad L, Johansen OE (2012)
Activin A and cardiovascular disease in type 2 diabetes mellitus
Diab Vasc Dis Res, 9 (3), 234-7
DOI 10.1177/1479164111431171, PubMed 22234949

Publications 2011

Birkeland KI, Home PD, Wendisch U, Ratner RE, Johansen T, Endahl LA, Lyby K, Jendle JH, Roberts AP, DeVries JH, Meneghini LF (2011)
Insulin degludec in type 1 diabetes: a randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargine
Diabetes Care, 34 (3), 661-5
DOI 10.2337/dc10-1925, PubMed 21270174

Gjelstad IM, Haugen F, Gulseth HL, Norheim F, Jans A, Bakke SS, Raastad T, Tjønna AE, Wisløff U, Blaak EE, Risérus U, Gaster M, Roche HM, Birkeland KI, Drevon CA (2011)
Expression of perilipins in human skeletal muscle in vitro and in vivo in relation to diet, exercise and energy balance
Arch Physiol Biochem, 118 (1), 22-30
DOI 10.3109/13813455.2011.630009, PubMed 22117101

Haukeland JW, Dahl TB, Yndestad A, Gladhaug IP, Løberg EM, Haaland T, Konopski Z, Wium C, Aasheim ET, Johansen OE, Aukrust P, Halvorsen B, Birkeland KI (2011)
Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies
Eur J Endocrinol, 166 (3), 503-10
DOI 10.1530/EJE-11-0864, PubMed 22170794

Jenum AK, Mørkrid K, Sletner L, Vangen S, Torper JL, Nakstad B, Voldner N, Rognerud-Jensen OH, Berntsen S, Mosdøl A, Skrivarhaug T, Vårdal MH, Holme I, Yajnik CS, Birkeland KI (2011)
Impact of ethnicity on gestational diabetes identified with the WHO and the modified International Association of Diabetes and Pregnancy Study Groups criteria: a population-based cohort study
Eur J Endocrinol, 166 (2), 317-24
DOI 10.1530/EJE-11-0866, PubMed 22108914

Søvik TT, Aasheim ET, Taha O, Engström M, Fagerland MW, Björkman S, Kristinsson J, Birkeland KI, Mala T, Olbers T (2011)
Weight loss, cardiovascular risk factors, and quality of life after gastric bypass and duodenal switch: a randomized trial
Ann Intern Med, 155 (5), 281-91
DOI 10.7326/0003-4819-155-5-201109060-00005, PubMed 21893621

Tran AT, Straand J, Diep LM, Meyer HE, Birkeland KI, Jenum AK (2011)
Cardiovascular disease by diabetes status in five ethnic minority groups compared to ethnic Norwegians
BMC Public Health, 11, 554
DOI 10.1186/1471-2458-11-554, PubMed 21752237

Aasheim ET, Elshorbagy AK, Diep LM, Søvik TT, Mala T, Valdivia-Garcia M, Olbers T, Bøhmer T, Birkeland KI, Refsum H (2011)
Effect of bariatric surgery on sulphur amino acids and glutamate
Br J Nutr, 106 (3), 432-40
DOI 10.1017/S0007114511000201, PubMed 21554803

Publications 2010

Atar D, Birkeland KI, Uhlig T (2010)
'Treat to target': moving targets from hypertension, hyperlipidaemia and diabetes to rheumatoid arthritis
Ann Rheum Dis, 69 (4), 629-30
DOI 10.1136/ard.2010.128462, PubMed 20237122

Birkeland KI (2010)
[Metabolic and cardiovascular health in mental disorders]
Tidsskr Nor Laegeforen, 130 (3), 285-6
DOI 10.4045/tidsskr.09.1194, PubMed 20160775

Charbonnel B, DeFronzo R, Davidson J, Schmitz O, Birkeland K, Pirags V, Scheen A, PROactive investigators (2010)
Pioglitazone use in combination with insulin in the prospective pioglitazone clinical trial in macrovascular events study (PROactive19)
J Clin Endocrinol Metab, 95 (5), 2163-71
DOI 10.1210/jc.2009-1974, PubMed 20237169

Dahl TB, Haukeland JW, Yndestad A, Ranheim T, Gladhaug IP, Damås JK, Haaland T, Løberg EM, Arntsen B, Birkeland K, Bjøro K, Ulven SM, Konopski Z, Nebb HI, Aukrust P, Halvorsen B (2010)
Intracellular nicotinamide phosphoribosyltransferase protects against hepatocyte apoptosis and is down-regulated in nonalcoholic fatty liver disease
J Clin Endocrinol Metab, 95 (6), 3039-47
DOI 10.1210/jc.2009-2148, PubMed 20392873

Gulseth HL, Gjelstad IM, Tierney AC, Lovegrove JA, Defoort C, Blaak EE, Lopez-Miranda J, Kiec-Wilk B, Risérus U, Roche HM, Drevon CA, Birkeland KI (2010)
Serum vitamin D concentration does not predict insulin action or secretion in European subjects with the metabolic syndrome
Diabetes Care, 33 (4), 923-5
DOI 10.2337/dc09-1692, PubMed 20067973

Gulseth HL, Gjelstad IM, Tierney AC, Shaw DI, Helal O, Hees AM, Delgado-Lista J, Leszczynska-Golabek I, Karlström B, Lovegrove J, Defoort C, Blaak EE, Lopez-Miranda J, Dembinska-Kiec A, Risérus U, Roche HM, Birkeland KI, Drevon CA (2010)
Dietary fat modifications and blood pressure in subjects with the metabolic syndrome in the LIPGENE dietary intervention study
Br J Nutr, 104 (2), 160-3
DOI 10.1017/S0007114510000565, PubMed 20202290

Hallén J, Johansen OE, Birkeland KI, Gullestad L, Aakhus S, Endresen K, Tjora S, Jaffe AS, Atar D (2010)
Determinants and prognostic implications of cardiac troponin T measured by a sensitive assay in type 2 diabetes mellitus
Cardiovasc Diabetol, 9, 52
DOI 10.1186/1475-2840-9-52, PubMed 20843304

Jenum AK, Sletner L, Voldner N, Vangen S, Mørkrid K, Andersen LF, Nakstad B, Skrivarhaug T, Rognerud-Jensen OH, Roald B, Birkeland KI (2010)
The STORK Groruddalen research programme: A population-based cohort study of gestational diabetes, physical activity, and obesity in pregnancy in a multiethnic population. Rationale, methods, study population, and participation rates
Scand J Public Health, 38 (5 Suppl), 60-70
DOI 10.1177/1403494810378921, PubMed 21062840

Solaas K, Legry V, Retterstol K, Berg PR, Holven KB, Ferrières J, Amouyel P, Lien S, Romeo J, Valtueña J, Widhalm K, Ruiz JR, Dallongeville J, Tonstad S, Rootwelt H, Halvorsen B, Nenseter MS, Birkeland KI, Thorsby PM, Meirhaeghe A, Nebb HI (2010)
Suggestive evidence of associations between liver X receptor β polymorphisms with type 2 diabetes mellitus and obesity in three cohort studies: HUNT2 (Norway), MONICA (France) and HELENA (Europe)
BMC Med Genet, 11, 144
DOI 10.1186/1471-2350-11-144, PubMed 20939869

Søvik TT, Irandoust B, Birkeland KI, Aasheim ET, Schou CF, Kristinsson J, Mala T (2010)
[Type 2 diabetes and metabolic syndrome before and after gastric bypass]
Tidsskr Nor Laegeforen, 130 (13), 1347-50
DOI 10.4045/tidsskr.09.0935, PubMed 20596116

Tran AT, Diep LM, Cooper JG, Claudi T, Straand J, Birkeland K, Ingskog W, Jenum AK (2010)
Quality of care for patients with type 2 diabetes in general practice according to patients' ethnic background: a cross-sectional study from Oslo, Norway
BMC Health Serv Res, 10, 145
DOI 10.1186/1472-6963-10-145, PubMed 20507647

Publications 2009

Birkenaes AB, Birkeland KI, Friis S, Opjordsmoen S, Andreassen OA (2009)
Hormonal markers of metabolic dysregulation in patients with severe mental disorders after olanzapine treatment under real-life conditions
J Clin Psychopharmacol, 29 (2), 109-16
DOI 10.1097/JCP.0b013e31819b95fc, PubMed 19512971

Haukeland JW, Konopski Z, Eggesbø HB, von Volkmann HL, Raschpichler G, Bjøro K, Haaland T, Løberg EM, Birkeland K (2009)
Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial
Scand J Gastroenterol, 44 (7), 853-60
DOI 10.1080/00365520902845268, PubMed 19811343

Johansen OE, Birkeland KI, Jørgensen AP, Orvik E, Sørgård B, Torjussen BR, Ueland T, Aukrust P, Gullestad L (2009)
Diabetic foot ulcer burden may be modified by high-dose atorvastatin: A 6-month randomized controlled pilot trial
J Diabetes, 1 (3), 182-7
DOI 10.1111/j.1753-0407.2009.00031.x, PubMed 20923537

Parhofer KG, Birkeland KI, DeFronzo R, Del Prato S, Bhaumik A, Ptaszynska A (2009)
Irbesartan has no short-term effect on insulin resistance in hypertensive patients with additional cardiometabolic risk factors (i-RESPOND)
Int J Clin Pract, 64 (2), 160-8
DOI 10.1111/j.1742-1241.2009.02246.x, PubMed 19929980

Scheen AJ, Tan MH, Betteridge DJ, Birkeland K, Schmitz O, Charbonnel B, PROactive investigators (2009)
Long-term glycaemic effects of pioglitazone compared with placebo as add-on treatment to metformin or sulphonylurea monotherapy in PROactive (PROactive 18)
Diabet Med, 26 (12), 1242-9
DOI 10.1111/j.1464-5491.2009.02857.x, PubMed 20002476

Thorsby PM, Midthjell K, Gjerlaugsen N, Holmen J, Hanssen KF, Birkeland KI, Berg JP (2009)
Comparison of genetic risk in three candidate genes (TCF7L2, PPARG, KCNJ11) with traditional risk factors for type 2 diabetes in a population-based study--the HUNT study
Scand J Clin Lab Invest, 69 (2), 282-7
DOI 10.1080/00365510802538188, PubMed 18972257

Yndestad A, Haukeland JW, Dahl TB, Bjøro K, Gladhaug IP, Berge C, Damås JK, Haaland T, Løberg EM, Linnestad P, Birkeland K, Konopski Z, Halvorsen B, Berge RK, Aukrust P (2009)
A complex role of activin A in non-alcoholic fatty liver disease
Am J Gastroenterol, 104 (9), 2196-205
DOI 10.1038/ajg.2009.318, PubMed 19532130

Aas AM, Hanssen KF, Berg JP, Thorsby PM, Birkeland KI (2009)
Insulin-stimulated increase in serum leptin levels precedes and correlates with weight gain during insulin therapy in type 2 diabetes
J Clin Endocrinol Metab, 94 (8), 2900-6
DOI 10.1210/jc.2008-1005, PubMed 19509109

Aas AM, Ohrvik J, Malmberg K, Rydén L, Birkeland KI, DIGAMI 2 Investigators (2009)
Insulin-induced weight gain and cardiovascular events in patients with type 2 diabetes. A report from the DIGAMI 2 study
Diabetes Obes Metab, 11 (4), 323-9
DOI 10.1111/j.1463-1326.2008.00964.x, PubMed 19267710

Aasheim ET, Frigstad SO, Søvik TT, Birkeland KI, Haukeland JW (2009)
Hyperinsulinemic hypoglycemia and liver cirrhosis presenting after duodenal switch: a case report
Surg Obes Relat Dis, 6 (4), 441-3
DOI 10.1016/j.soard.2009.11.007, PubMed 20096646

Publications 2008

Birkeland KI (2008)
[Overweight in diabetes--what is the best treatment?]
Tidsskr Nor Laegeforen, 128 (4), 445-6
PubMed 18309536

Birkenaes AB, Birkeland KI, Engh JA, Faerden A, Jonsdottir H, Ringen PA, Friis S, Opjordsmoen S, Andreassen OA (2008)
Dyslipidemia independent of body mass in antipsychotic-treated patients under real-life conditions
J Clin Psychopharmacol, 28 (2), 132-7
DOI 10.1097/JCP.0b013e318166c4f7, PubMed 18344722

Kase ET, Birkeland KI (2008)
[Antidiabetics which affect the incretin system]
Tidsskr Nor Laegeforen, 128 (4), 440-2
PubMed 18274578

Ribu L, Birkeland K, Hanestad BR, Moum T, Rustoen T (2008)
A longitudinal study of patients with diabetes and foot ulcers and their health-related quality of life: wound healing and quality-of-life changes
J Diabetes Complications, 22 (6), 400-7
DOI 10.1016/j.jdiacomp.2007.06.006, PubMed 18413188

Aasheim ET, Hofsø D, Hjelmesaeth J, Birkeland KI, Bøhmer T (2008)
Vitamin status in morbidly obese patients: a cross-sectional study
Am J Clin Nutr, 87 (2), 362-9
DOI 10.1093/ajcn/87.2.362, PubMed 18258626

Publications 2007

Birkenaes AB, Opjordsmoen S, Brunborg C, Engh JA, Jonsdottir H, Ringen PA, Simonsen C, Vaskinn A, Birkeland KI, Friis S, Sundet K, Andreassen OA (2007)
The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: a comparative study
J Clin Psychiatry, 68 (6), 917-23
DOI 10.4088/jcp.v68n0614, PubMed 17592917

Johansen OE, Birkeland KI (2007)
Defining the role of repaglinide in the management of type 2 diabetes mellitus: a review
Am J Cardiovasc Drugs, 7 (5), 319-35
DOI 10.2165/00129784-200707050-00002, PubMed 17953471

Johansen OE, Birkeland KI, Orvik E, Flesland Ø, Wergeland R, Ueland T, Smith C, Endresen K, Aukrust P, Gullestad L (2007)
Inflammation and coronary angiography in asymptomatic type 2 diabetic subjects
Scand J Clin Lab Invest, 67 (3), 306-16
DOI 10.1080/00365510601045088, PubMed 17454845

Johansen OE, Bjurö T, Endresen K, Blaasaas KG, Birkeland K, Aakhus S, Gullestad L (2007)
Heart rate adjustments and analysis of recovery patterns of ST-segment depression in type 2 diabetes
Int J Cardiol, 127 (1), 129-32
DOI 10.1016/j.ijcard.2007.04.022, PubMed 17532067

Johansen OE, Gullestad L, Blaasaas KG, Orvik E, Birkeland KI (2007)
Effects of structured hospital-based care compared with standard care for Type 2 diabetes-The Asker and Baerum Cardiovascular Diabetes Study, a randomized trial
Diabet Med, 24 (9), 1019-27
DOI 10.1111/j.1464-5491.2007.02198.x, PubMed 17509068

Ribu L, Hanestad BR, Moum T, Birkeland K, Rustoen T (2007)
Health-related quality of life among patients with diabetes and foot ulcers: association with demographic and clinical characteristics
J Diabetes Complications, 21 (4), 227-36
DOI 10.1016/j.jdiacomp.2007.02.001, PubMed 17616352

Publications 2006

Bergersen BM, Schumacher A, Sandvik L, Bruun JN, Birkeland K (2006)
Important differences in components of the metabolic syndrome between HIV-patients with and without highly active antiretroviral therapy and healthy controls
Scand J Infect Dis, 38 (8), 682-9
DOI 10.1080/00365540500361302, PubMed 16857615

Birkeland KI (2006)
[Insulin treatment of type 1 diabetes in adults]
Tidsskr Nor Laegeforen, 126 (6), 776-8
PubMed 16541173

Birkeland KI (2006)
[Insulin treatment in type 2 diabetes]
Tidsskr Nor Laegeforen, 126 (7), 919-20
PubMed 16554885

Birkeland KI (2006)
[Clinical use of long-acting insulin analogs]
Tidsskr Nor Laegeforen, 126 (8), 1067-8
PubMed 16619068

Gustafsson I, Malmberg K, Rydén L, Wedel H, Birkeland K, Bootsma A, Dickstein K, Efendic S, Fisher M, Hamsten A, Herlitz J, Hildebrandt PR, MacLeod K, Laakso M, Torp-Pedersen CT, Waldenström A, DIGAMI-2 investigatorerne (2006)
[Metabolic control by means of insulin in patients with type 2 diabetes and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity--secondary publication]
Ugeskr Laeger, 168 (6), 581-4
PubMed 16476220

Haukeland JW, Damås JK, Konopski Z, Løberg EM, Haaland T, Goverud I, Torjesen PA, Birkeland K, Bjøro K, Aukrust P (2006)
Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2
J Hepatol, 44 (6), 1167-74
DOI 10.1016/j.jhep.2006.02.011, PubMed 16618517

Jenum AK, Anderssen SA, Birkeland KI, Holme I, Graff-Iversen S, Lorentzen C, Ommundsen Y, Raastad T, Odegaard AK, Bahr R (2006)
Promoting physical activity in a low-income multiethnic district: effects of a community intervention study to reduce risk factors for type 2 diabetes and cardiovascular disease: a community intervention reducing inactivity
Diabetes Care, 29 (7), 1605-12
DOI 10.2337/dc05-1587, PubMed 16801586

Johansen OE, Birkeland KI, Brustad E, Aaser E, Lindahl AK, Midha R, Ueland T, Aukrust P, Gullestad L (2006)
Undiagnosed dysglycaemia and inflammation in cardiovascular disease
Eur J Clin Invest, 36 (8), 544-51
DOI 10.1111/j.1365-2362.2006.01679.x, PubMed 16893376

Ribu L, Hanestad BR, Moum T, Birkeland K, Rustoen T (2006)
A comparison of the health-related quality of life in patients with diabetic foot ulcers, with a diabetes group and a nondiabetes group from the general population
Qual Life Res, 16 (2), 179-89
DOI 10.1007/s11136-006-0031-y, PubMed 17091370

Ribu L, Rustøen T, Birkeland K, Hanestad BR, Paul SM, Miaskowski C (2006)
The prevalence and occurrence of diabetic foot ulcer pain and its impact on health-related quality of life
J Pain, 7 (4), 290-9
DOI 10.1016/j.jpain.2005.12.002, PubMed 16618473

Aas AM, Seljeflot I, Torjesen PA, Diep LM, Thorsby PM, Birkeland KI (2006)
Blood glucose lowering by means of lifestyle intervention has different effects on adipokines as compared with insulin treatment in subjects with type 2 diabetes
Diabetologia, 49 (5), 872-80
DOI 10.1007/s00125-006-0205-8, PubMed 16555056

Publications 2005

Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi-Benedetti M, Moules IK, Skene AM, Tan MH, Lefèbvre PJ, Murray GD, Standl E, Wilcox RG, Wilhelmsen L, Betteridge J, Birkeland K, Golay A, Heine RJ, Korányi L, Laakso M, Mokán M, Norkus A, Pirags V, Podar T, Scheen A, Scherbaum W et al. (2005)
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial
Lancet, 366 (9493), 1279-89
DOI 10.1016/S0140-6736(05)67528-9, PubMed 16214598

Haukeland JW, Konopski Z, Linnestad P, Azimy S, Marit Løberg E, Haaland T, Birkeland K, Bjøro K (2005)
Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease
Scand J Gastroenterol, 40 (12), 1469-77
DOI 10.1080/00365520500264953, PubMed 16293559

Hjeltnes N, De Groot P, Birkeland KI, Falch JA, Iversen PO (2005)
Tetraplegic subjects have hyperleptinaemia with marked circadian variation
Clin Endocrinol (Oxf), 62 (2), 223-7
DOI 10.1111/j.1365-2265.2005.02204.x, PubMed 15670200

Jenum AK, Holme I, Graff-Iversen S, Birkeland KI (2005)
Ethnicity and sex are strong determinants of diabetes in an urban Western society: implications for prevention
Diabetologia, 48 (3), 435-9
DOI 10.1007/s00125-005-1668-8, PubMed 15729578

Johansen OE, Birkeland KI (2005)
[Misleading about insulin administration to patients with diabetes]
Tidsskr Nor Laegeforen, 125 (16), 2247; author reply 2247
PubMed 16138161

Kilhovd BK, Juutilainen A, Lehto S, Rönnemaa T, Torjesen PA, Birkeland KI, Berg TJ, Hanssen KF, Laakso M (2005)
High serum levels of advanced glycation end products predict increased coronary heart disease mortality in nondiabetic women but not in nondiabetic men: a population-based 18-year follow-up study
Arterioscler Thromb Vasc Biol, 25 (4), 815-20
DOI 10.1161/01.ATV.0000158380.44231.fe, PubMed 15692098

Os I, Os A, Abdelnoor M, Larsen A, Birkeland K, Westheim A (2005)
Insulin sensitivity in women with coronary heart disease during hormone replacement therapy
J Womens Health (Larchmt), 14 (2), 137-45
DOI 10.1089/jwh.2005.14.137, PubMed 15775731

Thorsby PM, Berg JP, Birkeland KI (2005)
Insulin gene variable number of tandem repeats is associated with increased fat mass during adolescence in non-obese girls
Scand J Clin Lab Invest, 65 (2), 163-8
DOI 10.1080/00365510510013622, PubMed 16025839

Aas AM, Bergstad I, Thorsby PM, Johannesen O, Solberg M, Birkeland KI (2005)
An intensified lifestyle intervention programme may be superior to insulin treatment in poorly controlled Type 2 diabetic patients on oral hypoglycaemic agents: results of a feasibility study
Diabet Med, 22 (3), 316-22
DOI 10.1111/j.1464-5491.2005.01421.x, PubMed 15717881

Publications 2004

Birkeland KI (2004)
Moderne prinsipper for insulinbehandling
In Diabeteshåndboken, Gyldendal akademisk, Oslo, s. 136-142
BIBSYS 041962524

Kølendorf K, Eriksson J, Birkeland KI, Kjellström T, Hreidarsson AB (2004)
Dose titration of repaglinide in patients with inadequately controlled type 2 diabetes
Diabetes Res Clin Pract, 64 (1), 33-40
DOI 10.1016/j.diabres.2003.10.006, PubMed 15036825

Nissen-Lie G, Birkeland K, Hemmersbach P, Skibeli V (2004)
Serum sTfR levels may indicate charge profiling of urinary r-hEPO in doping control
Med Sci Sports Exerc, 36 (4), 588-93
DOI 10.1249/01.mss.0000121953.90379.a7, PubMed 15064585

Nissen-Lie G, Birkeland KI, Hemmersbach P, Skibeli V (2004)
Serum sTfR levels may indicate charge profiling of urinary R-hEPO in doping control
In Medicine and science in sports and exercise, American College of Sports Medicine, Madison, 36(2004)4, S. 588-93
BIBSYS 051823705

Stene LC, Midthjell K, Jenum AK, Skeie S, Birkeland KI, Lund E, Joner G, Tell GS, Schirmer H (2004)
[Prevalence of diabetes mellitus in Norway]
Tidsskr Nor Laegeforen, 124 (11), 1511-4
PubMed 15195154

Stene LCM, Midthjell K, Jenum AK, Skeie S, Birkeland KI, Lund E, Joner G, Tell GS, Schirmer H (2004)
Hvor mange har Diabetes Mellitus i Norge?
In Tidsskrift for Den norske legeforening, Foreningen, Oslo, 124(2004)nr. 11, S. 1511-1514
BIBSYS 05184432x

Aas AM, Birkeland KI, Seljeflot I (2004)
Effects of lifestyle intervention and insulin treatment on PAI-1, Hs-CRP and TNF-alfa levels in patients with Type 2 diabetes
In Diabetologia, Springer, Berlin, 47(2004)S1, S. A295 Abstrakt nr 818
BIBSYS 052055523

Publications 2003

Abebe F, Birkeland KI, Gaarder PI, Petros B, Gundersen SG (2003)
The relationships between dehydroepiandrosterone sulphate (DHEAS), the intensity of Schistosoma mansoni infection and parasite-specific antibody responses. A cross-sectional study in residents of endemic communities in north-east Ethiopia
APMIS, 111 (2), 319-28
DOI 10.1034/j.1600-0463.2003.1110205.x, PubMed 12716389

Birkeland KI, Gaarder PI, Petros B, Gundersen SG, Abebe F (2003)
The relationships between dehydroepiandrosterone sulphate(DHEAS), the intensity of Schistosoma mansoni infection and parasite-specific antibody responses: a cross sectional study in residents of endemic communities in north-easth Ethiopia
In APMIS, Blackwell Munksgaard, Copenhagen, 111(2003)2, s.319-28
BIBSYS 041704452

Birkeland KI, Kilhovd B, Thorsby P, Torjesen PA, Ganss R, Vaaler S, Hanssen KF (2003)
Heterogeneity of non-insulin-dependent diabetes expressed as variability in insulin sensitivity, beta-cell function and cardiovascular risk profile
Diabet Med, 20 (1), 37-45
DOI 10.1046/j.1464-5491.2003.00838.x, PubMed 12519318

Birkeland KI, Kilhovd BK, Thorsby P, Torjesen PA, Ganss R, Vaaler S, Hanssen KF (2003)
Heterogeneity of non-insulin-dependent diabetes expressedas variability in insulin sensitivity, beta-cell function and cardiovascular risk profile
In Diabetic medicine, John Wiley, Chichester, 20(2003)1, s.37-45
BIBSYS 04170732x

Bleskestad IH, Birkeland KI (2003)
[Differences between oral antidiabetics]
Tidsskr Nor Laegeforen, 123 (6), 808-9
PubMed 12693123

Bleskestad IH, Birkeland KI (2003)
Forskjeller mellom perorale antidiabetika
In Tidsskrift for Den norske legeforening, Foreningen, Oslo, 123(2003)nr. 6, S. 808-809
BIBSYS 041707575

Claudi T, Birkeland K, Jensen T (2003)
[Statins and diabetes--indications and refusal rules]
Tidsskr Nor Laegeforen, 123 (11), 1564-5
PubMed 12822023

DeGroot PC, Hjeltnes N, Heijboer AC, Stal W, Birkeland KI (2003)
Effect of training intensity on physical capacity, lipid profile and insulin sensitivity in early rehabilitation of spinal cord injured individuals
In Spinal cord, Stockton, Houndmills, 41(2003)12, s.673-9
BIBSYS 04170777x

Jenum AK, Birkeland KI (2003)
"Mosjon på Romsås" (MORO): et helsefremmende intervensjonsprosjekt for å fremme fysisk aktivitet i et mulit-etnisk lokalsamfunn i Oslo øst
In Data fra SHUS: bakgrunn og anvendelse : tema, Institutt for kjemi, Norges teknisk-naturvitenskapelige universitet, Trondheim, s.55-63
BIBSYS 041718496

Jenum AK, Lorentzen C, Anderssen S, Birkeland KI, Holme I, Lund-Larsen PG, Ommundsen Y, Raastad T, Thelle D, Bahr R (2003)
Promoting physical activity in a multi-ethnic district: methods and baseline results of a pseudo-experimental intervention study
In European journal of cardiovascular nursing, Elsevier, Amsterdam, 10(2003)5, s.387-96
BIBSYS 041718623

Johansen OE, Birkeland KI (2003)
Preventing macrovascular disease in patients with type 2 diabetes mellitus
Am J Cardiovasc Drugs, 3 (4), 283-97
DOI 10.2165/00129784-200303040-00007, PubMed 14728081

Johansen OE, Birkeland KI (2003)
Preventing macrovascular disease in patients with type 2 diabetes mellitus
In American journal of cardiovascular pathology, Field & Woods, Philadelphia, 3(2003)4, s.283-97
BIBSYS 041719182

Karen Jenum A, Lorentzen C, Anderssen SA, Birkeland KI, Holme I, Lund-Larsen PG, Ommundsen Y, Raastad T, Thelle DS, Bahr R (2003)
Promoting physical activity in a multi-ethnic district - methods and baseline results of a pseudo-experimental intervention study
Eur J Cardiovasc Prev Rehabil, 10 (5), 387-96
DOI 10.1097/01.hjr.0000085244.65733.94, PubMed 14663301

Kilhovd BK, Giardino I, Torjesen PA, Birkeland KI, Berg TJ, Thornalley PJ, Brownlee M, Hanssen KF (2003)
Increased serum levels of the specific AGE-compound methylglyoxal-derived hydroimidazolone in patients with type 2 diabetes
Metabolism, 52 (2), 163-7
DOI 10.1053/meta.2003.50035, PubMed 12601626

Kilhovd BK, Giardino I, Torjesen PA, Birkeland KI, Berg TJ, Thornalley PJ, Brownlee M, Hanssen KF (2003)
Increased serum levels of the specific AGE-compound methylglyoxal-derived hydroimidazolone in patients with type 2 diabetes
In Metabolism, Grune & Stratton, New York, 52(2003)2, s.163-7
BIBSYS 041719271

Kumar BN, Jenum AK, Birkeland KI, Holmboe-Ottesen G (2003)
Ethnic differences in the prevalence and determinants of diabetes type 2 in Oslo, Norway
In Diabetologia, Springer, Berlin, 46(2003)suppl 2, s.A37 abstract 101
BIBSYS 041734505

Os I, Høieggen A, Larsen A, Sandset PM, Djurovic S, Berg K, Os A, Birkeland KI, Westheim A (2003)
Smoking and relation to other risk factors in postmenopausal women with coronary artery disease, with particular reference to whole blood viscosity and beta-cell function
In Journal of internal medicine, Blackwell Scientific Publ., Oxford, 253(2003)2, s.232-9
BIBSYS 041722221

Sandvik L, Dunlop O, Birkeland KI, Bruun JN, Bergersen BM (2003)
Prevalence of hypertension in HIV-positive patients on highly active retroviral therapy (HAART) compared with HAART-naive and HIV-negative controls: results from a Norwegian study of 721 patients
In European journal of clinical microbiology & infectious diseases, Vieweg, Wiesbaden, 22(2003)12, s.731-6
BIBSYS 041705173

Thorsby PM, Blekastad I, Sletmo R, Hanssen KF, Birkeland KI (2003)
Non-glucose stimulated early insulin secretion is presenteven after long duration of type 2 diabetes
In Diabetologia, Springer, Berlin, 46(2003)suppl 2, s.A168 abstract 478
BIBSYS 041735986

Publications 2002

Birkeland KI (2002)
[Can diabetes be prevented?]
Tidsskr Nor Laegeforen, 122 (2), 155
PubMed 11873567

Birkeland KI (2002)
Kan vi forebygge diabetes?
In Tidsskrift for Den norske legeforening, Foreningen, Oslo, 122(2002)nr. 2, S. 155
BIBSYS 031265405

Publications 2001

Birkeland KI (2001)
[Glitazones--a new therapeutic principle in diabetes]
Tidsskr Nor Laegeforen, 121 (22), 2617-9
PubMed 11668762

Birkeland KI (2001)
Glitazoner: et nytt behandlingsprinsipp ved diabetes
In Tidsskrift for Den norske legeforening, Foreningen, Oslo, 121(2001)nr. 22, S. 2617-2619
BIBSYS 022031774

Birkeland KI (2001)
Glitazoner: et nytt behandlingsprinsipp ved diabetes
In Tidsskrift for Den norske legeforening, Foreningen, Oslo, 121(2001)nr. 22, S. 2617-2619
BIBSYS 022080759

Birkeland KI (2001)
Kan vi forebygge diabetes?
In Tidsskrift for Den norske legeforening, Foreningen, Oslo, 122(2001)nr. 2, S. 155
BIBSYS 022080899

Birkeland KI, Berg JP (2001)
Type 2 diabetes--preventable, but how?
Eur J Endocrinol, 145 (5), 573-5
DOI 10.1530/eje.0.1450573, PubMed 11720873

Birkeland KI, Berg JP (2001)
Type 2 diabetes: preventable, but how?
In European journal of endocrinology, BioScientifa Ltd., Bristol, 145(2001)nr 5, s.573-575
BIBSYS 022029834

Haug E, Birkeland KI (2001)
Hormones and athletic performance
In Endocrinology and metabolism, McGraw-Hill, London, 2001, s.777-783
BIBSYS 022033173

Jenssen TG, Kumar PD, Lund KK, Brekke IB, Birkeland KI, Hartmann A (2001)
Preserved long-time beta cell function and glucose turnover in kidneypancreas transplant patients
In Diabetologia, Springer, Berlin, 44(2001)suppl 1, s.A73 Abstrakt nr 274
BIBSYS 022033688

Thorsby P, Kilhovd B, Birkeland KI (2001)
A single measurement of HBA1c or fasting blood glucose inthe early phase of type 2 diabetes predict long term glycaemic control
In Diabetologia, Springer, Berlin, 44(2001)suppl 1, s.A229 Abstrakt nr 880
BIBSYS 022035729

Aas AM, Bergstad I, Johannessen Ø, Birkeland KI (2001)
Intensified lifestyle intervention of insulin treatment in type 2 diabetic patients with failure on oral hypoglycemic agents: which is best?
In Diabetologia, Springer, Berlin, 44(2001)suppl 1, s.A231 Abstrakt nr 887
BIBSYS 022035907

Publications 2000

Birkeland KI (2000)
Insulinresistens: hva er det og hvordan måles det?
In Diabetes for helsepersonell, Norges diabetesforbund, Oslo, 15(2000)nr 4, s.4-6
BIBSYS 010869042

Birkeland KI, Claudi T, Hansteen V, Hanssen KF, Hjermann I, Jenssen T, Jervell J, Os I (2000)
[Prevention of cardiovascular disease in type 2 diabetes]
Tidsskr Nor Laegeforen, 120 (21), 2554-9
PubMed 11070996

Birkeland KI, Claudi T, Hansteen V, Hanssen KF, Jenssen T, Jervell JA, Os I (2000)
Forebygging av hjerte- og karsykdom ved type 2-diabetes
In Tidsskrift for Den norske legeforening, Foreningen, Oslo, 120(2000)nr. 21, S. 2554-2559
BIBSYS 010758151

Birkeland KI, Stray-Gundersen J, Hemmersbach P, Hallen J, Haug E, Bahr R (2000)
Effect of rhEPO administration on serum levels of sTfR and cycling performance
Med Sci Sports Exerc, 32 (7), 1238-43
DOI 10.1097/00005768-200007000-00009, PubMed 10912888

Birkeland KI, Stray-Gundersen J, Hemmersbach P, Hallén J, Haug E, Bahr R (2000)
Effect of rhEPO administration on serum levels of sTfR and cycling performance
In Medicine and science in sports and exercise, American College of Sports Medicine, Madison, 32(2000)nr 7, s.1238-1243
BIBSYS 010829059

Haug E, Birkeland KI, Hemmersbach H (2000)
Doping og idrettsutøvere
In Medicinsk årbog 2000, s.9-18
BIBSYS 010834362

Kilhovd B, Giardino I, Torjesen PA, Birkeland KI, Thornalley PJ, Brownlee M, Hanssen KF (2000)
Increased serum methylglyoxal-derived hydroimidazolone inpatients with type 2 diabetes
In Diabetologia, Springer, Berlin, 43(2000)Suppl.1, s.A53 210
BIBSYS 01078408x

Kilhovd B, Giardino I, Torjesen PA, Birkeland KI, Thornalley PJ, Brownlee M, Hanssen KF (2000)
Increased serum methylglyoxal-derived hydroimidazolone inpatients with type 2 diabetes
In European journal of endocrinology, Supplementum, BioScientifica Ltd., Bristol, 142(2000)Suppl 1, s.26
BIBSYS 010890785

Os I, Hofstad AE, Brekke M, Abdelnoor M, Nesheim BI, Jacobsen AF, Birkeland KI, Larsen A, Midtbø K, Bestheim A (2000)
The EWA (estrogen in women with atherosclerosis) study: a randomized study of the use of hormone replacement therapy in women with angiographically verified coronary artery disease. Characteristics of the study population. Effects on lipids and lipoproteins
In Journal of internal medicine, Blackwell Scientific Publ., Oxford, 247(2000)nr 4, s.433-443
BIBSYS 010830138

Thorsby P, Kilhovd B, Sletmo R, Martinsen S, Birkeland KI (2000)
[Hypoglycemic treatment of type 2 diabetes]
Tidsskr Nor Laegeforen, 120 (20), 2434-40
PubMed 11475233

Thorsby P, Kilhovd B, Sletmo R, Martinsen S, Birkeland KI (2000)
Blodsukkersenkende behandling ved type 2-diabetes
In Tidsskrift for Den norske legeforening, Foreningen, Oslo, 120(2000)nr. 20, S. 2434-2440
BIBSYS 010831576

Tonstad S, Birkeland KI (2000)
[The obesity epidemics--do diet pills have a place in the treatment?]
Tidsskr Nor Laegeforen, 120 (17), 1997-2001
PubMed 11008533

Tonstad S, Birkeland KI (2000)
Fedmeepidemien: har slankepiller en plass i behandlingen?
In Tidsskrift for Den norske legeforening, Foreningen, Oslo, 120(2000)nr. 17, S. 1997-2001
BIBSYS 010831657

Publications 1999

Birkeland KI (1999)
The future of doping control in athletes: issues related to blood sampling
In Sports medicine, Adis International, Auckland, 28(1999)nr 1, S. 25-33
BIBSYS 991506774

Birkeland KI, Hemmersbach P (1999)
The future of doping control in athletes. Issues related to blood sampling
Sports Med, 28 (1), 25-33
DOI 10.2165/00007256-199928010-00003, PubMed 10461710

Kilhovd BK, Berg TJ, Birkeland KI, Thorsby P, Hanssen KF (1999)
Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease
Diabetes Care, 22 (9), 1543-8
DOI 10.2337/diacare.22.9.1543, PubMed 10480523

Publications 1998

Birkeland KI (1998)
Improving glycaemic control with current therapies
Diabet Med, 15 Suppl 4, S13-9
DOI 10.1002/(sici)1096-9136(1998120)15:4+3.3.co;2-e, PubMed 9868986

Hanssen KF, Birkeland KI, Thorsby P (1998)
[Type 2-diabetes consists of several diseases]
Tidsskr Nor Laegeforen, 118 (7), 1025
PubMed 9531820

Lorentzen B, Birkeland KI, Endresen MJ, Henriksen T (1998)
Glucose intolerance in women with preeclampsia
Acta Obstet Gynecol Scand, 77 (1), 22-7
DOI 10.1080/00016349808565805, PubMed 9492712

Thorsby P, Undlien DE, Berg JP, Thorsby E, Birkeland KI (1998)
[Diabetes mellitus--a complex interaction between heredity and environment]
Tidsskr Nor Laegeforen, 118 (16), 2519-24
PubMed 9667132

Tomten SE, Falch JA, Birkeland KI, Hemmersbach P, Høstmark AT (1998)
Bone mineral density and menstrual irregularities. A comparative study on cortical and trabecular bone structures in runners with alleged normal eating behavior
Int J Sports Med, 19 (2), 92-7
DOI 10.1055/s-2007-971888, PubMed 9562216

Publications 1997

Birkeland KI, Donike M, Ljungqvist A, Fagerhol M, Jensen J, Hemmersbach P, Oftebro H, Haug E (1997)
Blood sampling in doping control. First experiences from regular testing in athletics
Int J Sports Med, 18 (1), 8-12
DOI 10.1055/s-2007-972587, PubMed 9059898

Hjeltnes N, Aksnes AK, Birkeland KI, Johansen J, Lannem A, Wallberg-Henriksson H (1997)
Improved body composition after 8 wk of electrically stimulated leg cycling in tetraplegic patients
Am J Physiol, 273 (3 Pt 2), R1072-9
DOI 10.1152/ajpregu.1997.273.3.R1072, PubMed 9321888

Toft I, Bønaa KH, Ingebretsen OC, Nordøy A, Birkeland KI, Jenssen T (1997)
Gender differences in the relationships between plasma plasminogen activator inhibitor-1 activity and factors linked to the insulin resistance syndrome in essential hypertension
Arterioscler Thromb Vasc Biol, 17 (3), 553-9
DOI 10.1161/01.atv.17.3.553, PubMed 9102176

Torjesen PA, Birkeland KI, Anderssen SA, Hjermann I, Holme I, Urdal P (1997)
Lifestyle changes may reverse development of the insulin resistance syndrome. The Oslo Diet and Exercise Study: a randomized trial
Diabetes Care, 20 (1), 26-31
DOI 10.2337/diacare.20.1.26, PubMed 9028689

Publications 1996

Birkeland KI, Rishaug U, Hanssen KF, Vaaler S (1996)
NIDDM: a rapid progressive disease. Results from a long-term, randomised, comparative study of insulin or sulphonylurea treatment
Diabetologia, 39 (12), 1629-33
DOI 10.1007/s001250050626, PubMed 8960854

Birkeland KI, Vaaler S, Hanssen KF (1996)
[Insulin treatment is of value--also in type 2 diabetes]
Tidsskr Nor Laegeforen, 116 (10), 1233-5
PubMed 8658397

Haug E, Birkeland KI, Hemmersbach P (1996)
[Doping legislation]
Tidsskr Nor Laegeforen, 116 (2), 297-8
PubMed 8633342

Publications 1995

Birkeland KI (1995)
Type 2 diabetes mellitus: studies on insulin secretion and action in relation to metabolic control and cardiovascular risk factors
Hormone Laboratory, Aker University Hospital, Oslo University, Oslo, 1 b. (flere pag.)
BIBSYS 950450715, ISBN 82-993390-0-6

Birkeland KI, Hanssen KF, Stranden E, Falch JA, Vaaler S (1995)
Insulin-mediated increase in calf blood flow is not related to blood pressure levels in patients with type 2 diabetes mellitus
Blood Press, 4 (2), 80-4
DOI 10.3109/08037059509077574, PubMed 7599758

Norli HR, Esbensen K, Westad F, Birkeland KI, Hemmersbach P (1995)
Chemometric evaluation of urinary steroid profiles in doping control
J Steroid Biochem Mol Biol, 54 (1-2), 83-8
DOI 10.1016/0960-0760(95)00114-f, PubMed 7632620

Rishaug U, Birkeland KI, Falch JA, Vaaler S (1995)
Bone mass in non-insulin-dependent diabetes mellitus
Scand J Clin Lab Invest, 55 (3), 257-62
DOI 10.3109/00365519509089621, PubMed 7638560

Samdal F, Birkeland KI, Ose L, Amland PF (1995)
Effect of large-volume liposuction on sex hormones and glucose- and lipid metabolism in females
Aesthetic Plast Surg, 19 (2), 131-5
DOI 10.1007/BF00450248, PubMed 7598023

Publications 1994

Birkeland KI (1994)
Towards blood sampling in doping control: the road ahead
In Blood samples in doping control: proceedings of the Second International Symposium on Drugs in Sport : Towards the Use of Blood Samples in Doping Control? Lillehammer, Norway, August 29-31, 1993, Pensumtjeneste, Oslo, S. 203-205
BIBSYS 990137910

Birkeland KI, Furuseth K, Melander A, Mowinckel P, Vaaler S (1994)
Long-term randomized placebo-controlled double-blind therapeutic comparison of glipizide and glyburide. Glycemic control and insulin secretion during 15 months
Diabetes Care, 17 (1), 45-9
DOI 10.2337/diacare.17.1.45, PubMed 8112188

Birkeland KI, Hanssen KF, Urdal P, Berg K, Vaaler S (1994)
A long-term, randomized, comparative study of insulin versus sulfonylurea therapy in type 2 diabetes
J Intern Med, 236 (3), 305-13
DOI 10.1111/j.1365-2796.1994.tb00801.x, PubMed 8077888

Birkeland KI, Jørgensen J, Hemmersbach P (1994)
[Endocrine effects of doping with androgenic anabolic steroids]
Tidsskr Nor Laegeforen, 114 (4), 426-8
PubMed 8009475

Birkeland KI, Torjesen PA, Eriksson J, Vaaler S, Groop L (1994)
Hyperproinsulinemia of type II diabetes is not present before the development of hyperglycemia
Diabetes Care, 17 (11), 1307-10
DOI 10.2337/diacare.17.11.1307, PubMed 7821172

Moan A, Nordby G, Os I, Birkeland KI, Kjeldsen SE (1994)
Relationship between hemorrheologic factors and insulin sensitivity in healthy young men
Metabolism, 43 (4), 423-7
DOI 10.1016/0026-0495(94)90070-1, PubMed 8159097

Publications 1993

Birkeland KI, Hanssen KF, Torjesen PA, Vaaler S (1993)
Level of sex hormone-binding globulin is positively correlated with insulin sensitivity in men with type 2 diabetes
J Clin Endocrinol Metab, 76 (2), 275-8
DOI 10.1210/jcem.76.2.8432768, PubMed 8432768

Samdal F, Amland PF, Sandsmark M, Birkeland KI (1993)
Diabetic lipohypertrophy treated with suction-assisted lipectomy
J Intern Med, 234 (5), 489-92
DOI 10.1111/j.1365-2796.1993.tb00782.x, PubMed 8228793

Publications 1992

Birkeland KI, Chatzipanagiotou F, Hanssen KF, Vaaler S (1992)
Relationship between blood pressure and in vivo action of insulin in type II (non-insulin-dependent) diabetic subjects
Metabolism, 41 (3), 301-5
DOI 10.1016/0026-0495(92)90275-f, PubMed 1542270

Birkeland KI, Gallefoss F, Olsson S, Haug E (1992)
Primary hyperparathyroidism or hypercalcaemia of malignancy?
Scand J Clin Lab Invest, 52 (4), 347-9
DOI 10.1080/00365519209088368, PubMed 1439519

Publications 1991

Birkeland KI, Falch JA, Gautvik KM, Gjestvang FT, Holst N, Haug E (1991)
[Determination of intact parathyroid hormone in patients with calcium metabolism disorders]
Tidsskr Nor Laegeforen, 111 (15), 1840-4
PubMed 1853314

Birkeland KI, Gullestad L, Torsvik H (1991)
[Cholesterol-lowering effect of oat]
Tidsskr Nor Laegeforen, 111 (17), 2081-5
PubMed 1871737